Epstein-Barr	O
virus	O
latent	B-protein
membrane	I-protein
protein-1	I-protein
triggers	O
AP-1	B-protein
activity	O
via	O
the	O
c-Jun	B-protein
N-terminal	O
kinase	O
cascade	O
.	O

The	O
Epstein-Barr	O
virus	O
latent	B-protein
membrane	I-protein
protein-1	I-protein
(	O
LMP-1	B-protein
)	O
is	O
an	O
integral	B-protein
membrane	I-protein
protein	I-protein
which	O
transforms	O
fibroblasts	B-cell_type
and	O
is	O
essential	O
for	O
EBV-mediated	O
B-cell	O
immortalization	O
.	O

LMP-1	B-protein
has	O
been	O
shown	O
to	O
trigger	O
cellular	O
NF-kappa	B-protein
B	I-protein
activity	O
which	O
,	O
however	O
,	O
can	O
not	O
fully	O
explain	O
the	O
oncogenic	O
potential	O
of	O
LMP-1	B-protein
.	O

Here	O
we	O
show	O
that	O
LMP-1	B-protein
induces	O
the	O
activity	O
of	O
the	O
AP-1	B-protein
transcription	I-protein
factor	I-protein
,	O
a	O
dimer	O
of	O
Jun/Jun	B-protein
or	I-protein
Jun/Fos	I-protein
proteins	I-protein
.	O

LMP-1	B-protein
effects	O
on	O
AP-1	B-protein
are	O
mediated	O
through	O
activation	O
of	O
the	O
c-Jun	B-protein
N-terminal	O
kinase	O
(	O
JNK	B-protein
)	O
cascade	O
,	O
but	O
not	O
the	O
extracellular	B-protein
signal-regulated	I-protein
kinase	I-protein
(	O
Erk	B-protein
)	O
pathway	O
.	O

Consequently	O
,	O
LMP-1	B-protein
triggers	O
the	O
activity	O
of	O
the	O
c-Jun	B-protein
N-terminal	I-protein
transactivation	I-protein
domain	I-protein
which	O
is	O
known	O
to	O
be	O
activated	O
upon	O
JNK	B-protein
-mediated	O
phosphorylation	O
.	O

Deletion	O
analysis	O
indicates	O
that	O
the	O
55	O
C-terminal	B-protein
amino	I-protein
acids	I-protein
of	O
the	O
LMP-1	B-protein
molecule	I-protein
,	O
but	O
not	O
its	O
TRAF	B-protein
interaction	I-protein
domain	I-protein
,	O
are	O
essential	O
for	O
AP-1	B-protein
activation	O
.	O

JNK	B-protein
-mediated	O
transcriptional	O
activation	O
of	O
AP-1	B-protein
is	O
the	O
direct	O
output	O
of	O
LMP	B-protein
-1-triggered	O
signaling	O
,	O
as	O
shown	O
by	O
an	O
inducible	O
LMP-1	B-protein
mutant	I-protein
.	O

Using	O
a	O
tetracycline-regulated	B-DNA
LMP-1	I-DNA
allele	I-DNA
,	O
we	O
demonstrate	O
that	O
JNK	B-protein
is	O
also	O
an	O
effector	O
of	O
non-cytotoxic	O
LMP-1	B-protein
signaling	O
in	O
B	B-cell_type
cells	I-cell_type
,	O
the	O
physiological	O
target	O
cells	O
of	O
EBV	O
.	O

In	O
summary	O
,	O
our	O
data	O
reveal	O
a	O
novel	O
effector	O
of	O
LMP-1	B-protein
,	O
the	O
SEK/	O
JNK	B-protein
/	O
c-Jun	B-protein
/	O
AP-1	B-protein
pathway	O
,	O
which	O
contributes	O
to	O
our	O
understanding	O
of	O
the	O
immortalizing	O
and	O
transforming	O
potential	O
of	O
LMP-1	B-protein
.	O

The	NULL
EMBO	NULL
Journal	NULL
Vol.16	NULL
No.21	NULL
pp.6478-6485	NULL
,	NULL
1997	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein-1	NULL
triggers	NULL
AP-1	NULL
activity	NULL
via	NULL
the	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
cascade	NULL
Arnd	NULL
Kieser	NULL
'	NULL
,	NULL
Ellen	NULL
Kilger	NULL
,	NULL
Olivier	NULL
Gires	NULL
,	NULL
Marius	NULL
Ueffing	NULL
,	NULL
Walter	NULL
Kolch	NULL
and	NULL
Wolfgang	NULL
Hammerschmidt	NULL
GSF-National	NULL
Research	NULL
Center	NULL
for	NULL
Environment	NULL
and	NULL
Health	NULL
,	NULL
Institute	NULL
for	NULL
Clinical	NULL
Molecular	NULL
Biology	NULL
and	NULL
Tumor	NULL
Genetics	NULL
,	NULL
Marchioninistrasse	NULL
25	NULL
,	NULL
D-81377	NULL
Miinchen	NULL
,	NULL
Germany	NULL
*Corresponding	NULL
author	NULL
e-mail	NULL
:	NULL
A.Kieser	NULL
@	NULL
gsf.de	NULL
The	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein-1	NULL
(	NULL
LMP	NULL
is	NULL
an	NULL
integral	NULL
membrane	NULL
protein	NULL
which	NULL
transforms	NULL
fibroblasts	NULL
and	NULL
is	NULL
essential	NULL
for	NULL
EBV-mediated	NULL
B-cell	NULL
immortalization	NULL
.	NULL

LMP-1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
trigger	NULL
cellular	NULL
NF-KB	NULL
activity	NULL
which	NULL
,	NULL
however	NULL
,	NULL
can	NULL
not	NULL
fully	NULL
explain	NULL
the	NULL
oncogenic	NULL
potential	NULL
of	NULL
LMP-1	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
LMP-1	NULL
induces	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
AP-1	NULL
transcription	NULL
factor	NULL
,	NULL
a	NULL
dimer	NULL
of	NULL
Jun/Jun	NULL
or	NULL
Jun/Fos	NULL
proteins	NULL
.	NULL

LMP-1	NULL
effects	NULL
on	NULL
AP-1	NULL
are	NULL
mediated	NULL
through	NULL
activation	NULL
of	NULL
the	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
cascade	NULL
,	NULL
but	NULL
not	NULL
the	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
(	NULL
Erk	NULL
)	NULL
pathway	NULL
.	NULL

Consequently	NULL
,	NULL
LMP-1	NULL
triggers	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
c-Jun	NULL
N-terminal	NULL
transactivation	NULL
domain	NULL
which	NULL
is	NULL
known	NULL
to	NULL
be	NULL
activated	NULL
upon	NULL
JNK-mediated	NULL
phosphorylation	NULL
.	NULL

Deletion	NULL
analysis	NULL
indicates	NULL
that	NULL
the	NULL
55	NULL
C-terminal	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
LMP-1	NULL
molecule	NULL
,	NULL
but	NULL
not	NULL
its	NULL
TRAF	NULL
interaction	NULL
domain	NULL
,	NULL
are	NULL
essential	NULL
for	NULL
AP-1	NULL
activation	NULL
.	NULL

JNK	NULL
-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
AP-1	NULL
is	NULL
the	NULL
direct	NULL
output	NULL
of	NULL
LMP-1-triggered	NULL
signaling	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
an	NULL
inducible	NULL
LMP-1	NULL
mutant	NULL
.	NULL

Using	NULL
a	NULL
tetracycline-regulated	NULL
LMP-1	NULL
allele	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
JNK	NULL
is	NULL
also	NULL
an	NULL
effector	NULL
of	NULL
non-cytotoxic	NULL
LMP-1	NULL
signaling	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
physiological	NULL
target	NULL
cells	NULL
of	NULL
EBV	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
our	NULL
data	NULL
reveal	NULL
a	NULL
novel	NULL
effector	NULL
of	NULL
LMP-1	NULL
,	NULL
the	NULL
SEK/JNK/c-Jun/AP-1	NULL
pathway	NULL
,	NULL
which	NULL
contributes	NULL
to	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
immortalizing	NULL
and	NULL
transforming	NULL
potential	NULL
of	NULL
LMP-1	NULL
.	NULL

Keywords	NULL
:	NULL
AP-1	NULL
transcription	NULL
factor/c-Jun	NULL
N-terminal	NULL
kinase	NULL
pathway/Epstein-Barr	NULL
virus/latent	NULL
membrane	NULL
protein-1/signal	NULL
transduction	NULL
Introduction	NULL
Epstein-Barr	NULL
Virus	NULL
(	NULL
EBV	NULL
)	NULL
is	NULL
a	NULL
human	NULL
herpes	NULL
virus	NULL
associated	NULL
with	NULL
several	NULL
human	NULL
cancers	NULL
such	NULL
as	NULL
Hodgkin	NULL
's	NULL
lymphoma	NULL
,	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
or	NULL
nasopharyngeal	NULL
carcinoma	NULL
(	NULL
for	NULL
a	NULL
review	NULL
see	NULL
Klein	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

EBV	NULL
efficiently	NULL
infects	NULL
resting	NULL
B	NULL
cells	NULL
in	NULL
vitro	NULL
,	NULL
which	NULL
results	NULL
in	NULL
the	NULL
immortalization	NULL
of	NULL
the	NULL
infected	NULL
cells	NULL
(	NULL
for	NULL
reviews	NULL
see	NULL
Farrell	NULL
,	NULL
1995	NULL
;	NULL
Kieff	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

This	NULL
process	NULL
constitutes	NULL
an	NULL
in	NULL
vitro	NULL
model	NULL
for	NULL
EBV	NULL
's	NULL
contribution	NULL
to	NULL
B	NULL
lymphoid	NULL
diseases	NULL
.	NULL

Among	NULL
the	NULL
11	NULL
EBV	NULL
genes	NULL
found	NULL
expressed	NULL
in	NULL
in	NULL
vitro	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
,	NULL
Epstein-Barr	NULL
viral	NULL
nuclear	NULL
antigen	NULL
2	NULL
(	NULL
EBNAZ	NULL
)	NULL
,	NULL
EBNA3a	NULL
and	NULL
3Â¢	NULL
and	NULL
latent	NULL
6478	NULL
membrane	NULL
protein-1	NULL
(	NULL
LMP-1	NULL
)	NULL
are	NULL
essential	NULL
for	NULL
the	NULL
immortalizing	NULL
functions	NULL
of	NULL
the	NULL
virus	NULL
(	NULL
Cohen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Hammerschmidt	NULL
and	NULL
Sugden	NULL
,	NULL
1989	NULL
;	NULL
Kaye	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Tomkinson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Kempkes	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995b	NULL
)	NULL
.	NULL

EBNA2	NULL
activates	NULL
the	NULL
transcription	NULL
of	NULL
several	NULL
viral	NULL
and	NULL
cellular	NULL
genes	NULL
by	NULL
interaction	NULL
with	NULL
the	NULL
cellular	NULL
DNA-binding	NULL
proteins	NULL
RBP-Jx	NULL
and	NULL
PU.1	NULL
which	NULL
bind	NULL
to	NULL
EBNA2Z-responsive	NULL
promoter	NULL
elements	NULL
(	NULL
Grossman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Henkel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Laux	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Zimber-Strobl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Thereby	NULL
,	NULL
EBNAZ	NULL
triggers	NULL
the	NULL
expression	NULL
of	NULL
B-cell	NULL
activation	NULL
markers	NULL
such	NULL
as	NULL
CD21	NULL
and	NULL
CD23	NULL
(	NULL
Cordier	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
tyrosine	NULL
kinase	NULL
c-fgr	NULL
(	NULL
Knutson	NULL
,	NULL
1990	NULL
)	NULL
,	NULL
and	NULL
viral	NULL
latent	NULL
genes	NULL
such	NULL
as	NULL
LMP-1	NULL
,	NULL
LMP-2A	NULL
and	NULL
LMP-2B	NULL
(	NULL
Fahraeus	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Laux	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Zimber-Strobl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

LMP-1	NULL
expression	NULL
is	NULL
not	NULL
only	NULL
necessary	NULL
for	NULL
B-cell	NULL
immortalization	NULL
by	NULL
EBV	NULL
(	NULL
Kaye	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
but	NULL
is	NULL
the	NULL
only	NULL
EBV	NULL
protein	NULL
that	NULL
has	NULL
an	NULL
oncogenic	NULL
potential	NULL
in	NULL
non-lymphoid	NULL
cells	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
LMP-1	NULL
in	NULL
rodent	NULL
fibroblasts	NULL
leads	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
transformed	NULL
phenotypes	NULL
(	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Baichwal	NULL
and	NULL
Sugden	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mechanisms	NULL
underlying	NULL
LMP-1	NULL
's	NULL
ability	NULL
to	NULL
immortalize	NULL
and	NULL
transform	NULL
B	NULL
cells	NULL
and	NULL
non-B	NULL
cells	NULL
are	NULL
not	NULL
fully	NULL
understood	NULL
.	NULL

In	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
LMP	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
B-cell	NULL
activation	NULL
markers	NULL
such	NULL
as	NULL
CD23	NULL
and	NULL
cell	NULL
adhesion	NULL
molecules	NULL
like	NULL
ICAM1	NULL
(	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

LMP-1	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
anti-apoptotic	NULL
genes	NULL
bel-2	NULL
(	NULL
Henderson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
and	NULL
A20	NULL
,	NULL
the	NULL
latter	NULL
via	NULL
induction	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
(	NULL
Laherty	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
transforming	NULL
potential	NULL
of	NULL
LMP-1	NULL
,	NULL
however	NULL
,	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
depend	NULL
on	NULL
NF-KB	NULL
activation	NULL
or	NULL
induction	NULL
of	NULL
bel-2	NULL
,	NULL
since	NULL
LMP-1	NULL
transforms	NULL
BALB/3T3	NULL
cells	NULL
without	NULL
inducing	NULL
NF-KB	NULL
or	NULL
bel-2	NULL
(	NULL
Baichwal	NULL
and	NULL
Sugden	NULL
,	NULL
1988	NULL
;	NULL
Martin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Mitchell	NULL
and	NULL
Sugden	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
LMP-1	NULL
does	NULL
not	NULL
affect	NULL
bel-2	NULL
expression	NULL
in	NULL
primary	NULL
human	NULL
B	NULL
cells	NULL
or	NULL
in	NULL
B-cell	NULL
lines	NULL
immortalized	NULL
by	NULL
EBV	NULL
(	NULL
Martin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Zimber-Strobl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

LMP-1	NULL
is	NULL
an	NULL
integral	NULL
membrane	NULL
protein	NULL
consisting	NULL
of	NULL
386	NULL
amino	NULL
acids	NULL
.	NULL

Six	NULL
transmembrane	NULL
spanning	NULL
domains	NULL
(	NULL
162	NULL
amino	NULL
acids	NULL
)	NULL
connect	NULL
a	NULL
short	NULL
N-terminal	NULL
stretch	NULL
(	NULL
24	NULL
amino	NULL
acids	NULL
)	NULL
with	NULL
a	NULL
long	NULL
C-terminal	NULL
domain	NULL
(	NULL
200	NULL
amino	NULL
acids	NULL
)	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
located	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
Liebowitz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Kieff	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

Little	NULL
is	NULL
known	NULL
about	NULL
LMP-1	NULL
's	NULL
molecular	NULL
functions	NULL
in	NULL
the	NULL
cell	NULL
.	NULL

The	NULL
C-terminus	NULL
of	NULL
LMP-1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor-associated	NULL
factors	NULL
(	NULL
TRAFs	NULL
)	NULL
1	NULL
,	NULL
2	NULL
and	NULL
3	NULL
(	NULL
Mosialos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Devergne	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Sandberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
suggesting	NULL
that	NULL
LMP-1	NULL
might	NULL
act	NULL
as	NULL
a	NULL
receptor-like	NULL
molecule	NULL
comparable	NULL
with	NULL
the	NULL
members	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
(	NULL
TNFR	NULL
)	NULL
superfamily	NULL
.	NULL

However	NULL
,	NULL
LMP-1	NULL
is	NULL
a	NULL
unique	NULL
molecule	NULL
.	NULL

It	NULL
is	NULL
not	NULL
homologous	NULL
to	NULL
any	NULL
of	NULL
the	NULL
known	NULL
TNFR	NULL
family	NULL
members	NULL
or	NULL
other	NULL
known	NULL
receptor	NULL
families	NULL
and	NULL
its	NULL
activity	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
depend	NULL
Â©	NULL
Oxford	NULL
University	NULL
Press	NULL
on	NULL
the	NULL
binding	NULL
of	NULL
a	NULL
specific	NULL
ligand	NULL
especially	NULL
because	NULL
LMP-1	NULL
lacks	NULL
an	NULL
extracellular	NULL
domain	NULL
(	NULL
Liebowitz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

So	NULL
far	NULL
,	NULL
induction	NULL
of	NULL
NF-KB	NULL
activity	NULL
is	NULL
the	NULL
only	NULL
known	NULL
direct	NULL
cellular	NULL
output	NULL
of	NULL
LMP-1	NULL
signaling	NULL
(	NULL
Hammarskjold	NULL
and	NULL
Simurda	NULL
,	NULL
1992	NULL
;	NULL
Laherty	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Kieff	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

LMP-1-triggered	NULL
signaling	NULL
to	NULL
NF-KB	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
initiated	NULL
at	NULL
the	NULL
C-terminal	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
LMP-1	NULL
(	NULL
Huen	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Mitchell	NULL
and	NULL
Sugden	NULL
,	NULL
1995	NULL
)	NULL
after	NULL
oligomerization	NULL
of	NULL
LMP-1	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
via	NULL
its	NULL
transmembrane	NULL
domains	NULL
(	NULL
Gires	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
NF-KB	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
involve	NULL
TRAF1l	NULL
and	NULL
2	NULL
(	NULL
Mosialos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Devergne	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
but	NULL
very	NULL
recent	NULL
data	NULL
show	NULL
that	NULL
LMP-1	NULL
mutants	NULL
which	NULL
do	NULL
not	NULL
bind	NULL
TRAFs	NULL
still	NULL
induce	NULL
NF-KB	NULL
activity	NULL
(	NULL
Sandberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Kaye	NULL
and	NULL
collegues	NULL
demonstrated	NULL
that	NULL
LMP-1	NULL
provides	NULL
a	NULL
growth	NULL
factor-like	NULL
effect	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
immortalization	NULL
of	NULL
B	NULL
lymphocytes	NULL
by	NULL
EBV	NULL
(	NULL
Kaye	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

As	NULL
discussed	NULL
above	NULL
,	NULL
NF-KB	NULL
activity	NULL
alone	NULL
is	NULL
unlikely	NULL
to	NULL
be	NULL
the	NULL
basis	NULL
for	NULL
LMP-1	NULL
's	NULL
transforming	NULL
and	NULL
immortalizing	NULL
potential	NULL
since	NULL
LMP-1	NULL
transforms	NULL
some	NULL
cells	NULL
without	NULL
inducing	NULL
NF-KB	NULL
(	NULL
Baichwal	NULL
and	NULL
Sugden	NULL
,	NULL
1988	NULL
;	NULL
Martin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Mitchell	NULL
and	NULL
Sugden	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
set	NULL
out	NULL
to	NULL
identify	NULL
new	NULL
nuclear	NULL
targets	NULL
of	NULL
LMP-1	NULL
signaling	NULL
that	NULL
could	NULL
help	NULL
to	NULL
explain	NULL
the	NULL
immortalizing	NULL
and	NULL
growth	NULL
factor-like	NULL
effects	NULL
of	NULL
LMP-1	NULL
.	NULL

A	NULL
prime	NULL
candidate	NULL
was	NULL
the	NULL
transcription	NULL
factor	NULL
AP-1	NULL
(	NULL
activator	NULL
protein-1	NULL
)	NULL
,	NULL
a	NULL
dimer	NULL
composed	NULL
of	NULL
Jun	NULL
or	NULL
Fos	NULL
familiy	NULL
proto-oncoproteins	NULL
binding	NULL
to	NULL
the	NULL
phorbol	NULL
12-O-tetradecanoate-13-actetate	NULL
(	NULL
TPA	NULL
)	NULL
-responsive	NULL
element	NULL
(	NULL
TRE	NULL
)	NULL
(	NULL
for	NULL
reviews	NULL
see	NULL
Angel	NULL
and	NULL
Karin	NULL
,	NULL
1991	NULL
;	NULL
Karin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
fos	NULL
and	NULL
jun	NULL
immediate	NULL
early	NULL
genes	NULL
is	NULL
tightly	NULL
linked	NULL
to	NULL
the	NULL
control	NULL
of	NULL
proliferation	NULL
as	NULL
well	NULL
as	NULL
the	NULL
induction	NULL
of	NULL
transformation	NULL
and	NULL
immortalization	NULL
of	NULL
various	NULL
cell	NULL
types	NULL
including	NULL
B	NULL
cells	NULL
(	NULL
Angel	NULL
and	NULL
Karin	NULL
,	NULL
1991	NULL
;	NULL
Karin	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
AP-1	NULL
transcription	NULL
factor	NULL
is	NULL
activated	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
growth	NULL
factors	NULL
and	NULL
mitogens	NULL
such	NULL
as	NULL
epidermal	NULL
growth	NULL
factor	NULL
(	NULL
EGF	NULL
)	NULL
,	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
(	NULL
PDGF	NULL
)	NULL
,	NULL
or	NULL
TPA	NULL
(	NULL
Angel	NULL
and	NULL
Karin	NULL
,	NULL
1991	NULL
;	NULL
Karin	NULL
,	NULL
1995	NULL
)	NULL
and	NULL
,	NULL
thus	NULL
,	NULL
mediates	NULL
growth	NULL
factor	NULL
effects	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
activated	NULL
viral	NULL
counterparts	NULL
of	NULL
cellular	NULL
c-jun	NULL
and	NULL
c-fos	NULL
,	NULL
v-jun	NULL
and	NULL
v-fos	NULL
,	NULL
have	NULL
both	NULL
been	NULL
described	NULL
as	NULL
potent	NULL
oncogenes	NULL
(	NULL
Angel	NULL
and	NULL
Karin	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
LMP-1	NULL
induces	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
AP-1	NULL
transcription	NULL
factor	NULL
via	NULL
a	NULL
signaling	NULL
pathway	NULL
which	NULL
involves	NULL
the	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
1	NULL
(	NULL
JNK1	NULL
)	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
the	NULL
proto-oncoprotein	NULL
AP-1	NULL
as	NULL
a	NULL
nuclear	NULL
target	NULL
of	NULL
LMP-1	NULL
signaling	NULL
provides	NULL
new	NULL
clues	NULL
to	NULL
the	NULL
immortalizing	NULL
and	NULL
transforming	NULL
potential	NULL
of	NULL
LMP-1	NULL
.	NULL

Results	NULL
Induction	NULL
of	NULL
AP-1-dependent	NULL
transcription	NULL
by	NULL
LMP-1	NULL
To	NULL
test	NULL
whether	NULL
LMP-1	NULL
can	NULL
activate	NULL
the	NULL
AP-1	NULL
transcription	NULL
factor	NULL
,	NULL
human	NULL
293	NULL
embryonic	NULL
kidney	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
an	NULL
LMP-1	NULL
expression	NULL
plasmid	NULL
together	NULL
with	NULL
an	NULL
AP-1	NULL
reporter	NULL
construct	NULL
,	NULL
which	NULL
consists	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
a	NULL
minimal	NULL
promoter	NULL
and	NULL
four	NULL
TREs	NULL
(	NULL
pRTU14	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
LMP-1	NULL
led	NULL
up	NULL
to	NULL
a	NULL
10-fold	NULL
induction	NULL
of	NULL
AP-1-driven	NULL
transcription	NULL
depending	NULL
on	NULL
the	NULL
amount	NULL
of	NULL
cotransfected	NULL
LMP-1	NULL
expression	NULL
plasmid	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

As	NULL
positive	NULL
controls	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
LMP-1	NULL
induces	NULL
AP-1	NULL
via	NULL
JNK	NULL
1	NULL
(	NULL
JNK1	NULL
)	NULL
or	NULL
the	NULL
constitutively	NULL
active	NULL
Raf-1	NULL
kinase	NULL
domain	NULL
(	NULL
BXB-Raf	NULL
)	NULL
(	NULL
Kieser	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
also	NULL
induced	NULL
AP-1-dependent	NULL
luciferase	NULL
activity	NULL
in	NULL
293	NULL
cells	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
LMP-1	NULL
expression	NULL
leads	NULL
to	NULL
a	NULL
strong	NULL
induction	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
AP-1	NULL
.	NULL

LMP-1	NULL
induces	NULL
JNK1	NULL
kinase	NULL
activity	NULL
but	NULL
not	NULL
Erk2	NULL
activity	NULL
The	NULL
next	NULL
step	NULL
was	NULL
to	NULL
elucidate	NULL
the	NULL
signaling	NULL
pathway	NULL
(	NULL
s	NULL
)	NULL
mediating	NULL
LMP-1	NULL
effects	NULL
on	NULL
AP-1	NULL
.	NULL

So	NULL
far	NULL
,	NULL
two	NULL
MAPK	NULL
(	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
)	NULL
pathways	NULL
have	NULL
been	NULL
identified	NULL
that	NULL
regulate	NULL
AP-1	NULL
activity	NULL
in	NULL
the	NULL
cell	NULL
,	NULL
the	NULL
Mek	NULL
-	NULL
>	NULL
Erk	NULL
pathway	NULL
,	NULL
which	NULL
is	NULL
activated	NULL
by	NULL
the	NULL
Raf-1	NULL
kinase	NULL
,	NULL
and	NULL
the	NULL
SEK	NULL
-	NULL
>	NULL
JNK	NULL
cascade	NULL
(	NULL
Karin	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
evaluate	NULL
LMP-1	NULL
's	NULL
ability	NULL
to	NULL
induce	NULL
either	NULL
one	NULL
or	NULL
both	NULL
of	NULL
these	NULL
pathways	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
LMP-1	NULL
activates	NULL
JNK1	NULL
or	NULL
Erk2	NULL
.	NULL

LMP-1	NULL
strongly	NULL
induced	NULL
the	NULL
kinase	NULL
activity	NULL
of	NULL
a	NULL
cotransfected	NULL
hemagglutinin	NULL
(	NULL
HA	NULL
)	NULL
-tagged	NULL
JNK1	NULL
(	NULL
HA-JNK1	NULL
)	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
in	NULL
293	NULL
cells	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

LMP-1	NULL
induced	NULL
JNK	NULL
]	NULL
kinase	NULL
activity	NULL
by	NULL
a	NULL
factor	NULL
of	NULL
7.8	NULL
which	NULL
is	NULL
comparable	NULL
with	NULL
the	NULL
LMP-1-triggered	NULL
activation	NULL
of	NULL
AP-1	NULL
(	NULL
see	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

As	NULL
positive	NULL
controls	NULL
,	NULL
crosslinking	NULL
of	NULL
a	NULL
cotransfected	NULL
CD40	NULL
receptor	NULL
(	NULL
Berberich	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
or	NULL
UV-irradiation	NULL
(	NULL
Derijard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
of	NULL
the	NULL
cells	NULL
also	NULL
caused	NULL
JNK1	NULL
activation	NULL
demonstrating	NULL
that	NULL
the	NULL
experimental	NULL
setup	NULL
was	NULL
working	NULL
properly	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
HA-JNK1	NULL
,	NULL
neither	NULL
Raf-l1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
nor	NULL
a	NULL
cotransfected	NULL
HA-Erk2	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
was	NULL
activated	NULL
by	NULL
LMP-1	NULL
.	NULL

These	NULL
findings	NULL
demonstrate	NULL
the	NULL
selectivity	NULL
of	NULL
the	NULL
LMP-1	NULL
signaling	NULL
process	NULL
.	NULL

LMP-1	NULL
efficiently	NULL
induces	NULL
the	NULL
JNK	NULL
cascade	NULL
but	NULL
not	NULL
the	NULL
Erk	NULL
cascade	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
these	NULL
findings	NULL
led	NULL
us	NULL
to	NULL
hypothesize	NULL
that	NULL
LMP-1	NULL
might	NULL
trigger	NULL
AP-1	NULL
specifically	NULL
via	NULL
the	NULL
JNK	NULL
pathway	NULL
.	NULL

LMP-1	NULL
induces	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
c-Jun	NULL
N-terminal	NULL
transactivation	NULL
domain	NULL
In	NULL
vivo	NULL
,	NULL
JINKs	NULL
but	NULL
not	NULL
Erks	NULL
activate	NULL
c-Jun	NULL
by	NULL
phosphorylation	NULL
of	NULL
serine	NULL
residues	NULL
63	NULL
and	NULL
73	NULL
in	NULL
its	NULL
N-terminal	NULL
transactivation	NULL
domain	NULL
(	NULL
Hibi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Derijard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Minden	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Westwick	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Karin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
LMP-1	NULL
induces	NULL
AP-1	NULL
via	NULL
the	NULL
N-terminal	NULL
transactivation	NULL
domain	NULL
of	NULL
c-Jun	NULL
,	NULL
LMP-1	NULL
was	NULL
transiently	NULL
expressed	NULL
together	NULL
with	NULL
a	NULL
chimeric	NULL
transcription	NULL
factor	NULL
,	NULL
c-Jun	NULL
:	NULL
E2	NULL
,	NULL
consisting	NULL
of	NULL
the	NULL
N-terminal	NULL
transactivation	NULL
domain	NULL
of	NULL
c-Jun	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
244	NULL
)	NULL
and	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
papilloma	NULL
virus	NULL
E2	NULL
protein	NULL
.	NULL

Transactivation	NULL
by	NULL
this	NULL
chimeric	NULL
transcription	NULL
factor	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
c-Jun	NULL
portion	NULL
of	NULL
the	NULL
fusion	NULL
protein	NULL
(	NULL
Baichwal	NULL
and	NULL
Tjian	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
transactivating	NULL
activity	NULL
of	NULL
c-Jun	NULL
:	NULL
E2	NULL
was	NULL
measured	NULL
in	NULL
transient	NULL
reporter	NULL
assays	NULL
using	NULL
a	NULL
reporter	NULL
construct	NULL
which	NULL
carries	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
seven	NULL
E2	NULL
binding	NULL
sites	NULL
,	NULL
7xE2-oriLyt-Luc	NULL
(	NULL
L	NULL
)	NULL
(	NULL
Schepers	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

LMP-1	NULL
caused	NULL
a	NULL
significant	NULL
increase	NULL
(	NULL
up	NULL
to	NULL
6.5-fold	NULL
)	NULL
of	NULL
the	NULL
transcriptional	NULL
activitiy	NULL
of	NULL
c-Jun	NULL
:	NULL
E2	NULL
in	NULL
a	NULL
dose-depend-ent	NULL
fashion	NULL
(	NULL
Figure	NULL
1C	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
transient	NULL
expression	NULL
of	NULL
JNK1	NULL
also	NULL
induced	NULL
c-Jun	NULL
:	NULL
E2	NULL
activity	NULL
in	NULL
the	NULL
same	NULL
range	NULL
as	NULL
LMP-1	NULL
,	NULL
whereas	NULL
expression	NULL
of	NULL
BXB-Raf	NULL
was	NULL
not	NULL
effective	NULL
(	NULL
Figure	NULL
1C	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
show	NULL
that	NULL
LMP-1	NULL
can	NULL
induce	NULL
AP-1	NULL
activity	NULL
via	NULL
the	NULL
c-Jun	NULL
N-terminal	NULL
transactivation	NULL
domain	NULL
and	NULL
strengthen	NULL
the	NULL
6479	NULL
A.Kieser	NULL
et	NULL
al	NULL
.	NULL

B	NULL
.	NULL

$	NULL
C.	NULL
x	NULL
x	NULL
$	NULL
53	NULL
8596	NULL
(	NULL
$	NULL
05	NULL
:	NULL
Â«	NULL
Q	NULL
?	NULL

A	NULL
gm	NULL
&	NULL
Â®	NULL
Â«	NULL
Â©	NULL
,	NULL
A	NULL
<	NULL
P	NULL
.	NULL

$	NULL
@	NULL
C	NULL
A	NULL
16.0	NULL
C53	NULL
}	NULL
(	NULL
â	NULL
gsâ00	NULL
3	NULL
(	NULL
0	NULL
&	NULL
be	NULL
Ay	NULL
>	NULL
&	NULL
14.0	NULL
â¬	NULL
Â®	NULL
12.0	NULL
HA-JNK1	NULL
activity	NULL
Â«	NULL
b	NULL
--	NULL
l	NULL
HA-Erk2	NULL
activity	NULL
f	NULL
a	NULL
(	NULL
GST-e-Jun~P	NULL
)	NULL
3	NULL
(	NULL
mep~P	NULL
)	NULL
ig	NULL
$	NULL
8	NULL
[	NULL
e	NULL
$	NULL
8	NULL
Â°	NULL
|	NULL
9	NULL
|	NULL
I	NULL
8	NULL
if	NULL
?	NULL

4.0	NULL
x-fold	NULL
induction	NULL
--	NULL
Â»	NULL
|	NULL
7.8	NULL
1.0	NULL
9.3	NULL
15.9	NULL
1.0	NULL
8.0	NULL
0.9	NULL
|	NULL
Â«	NULL
-	NULL
x-fold	NULL
induction	NULL
5	NULL
&	NULL
-	NULL
20	NULL
Â§	NULL
oo	NULL
m	NULL
me	NULL
W	NULL
m_	NULL
m	NULL
ma	NULL
H	NULL
e_	NULL
Â§	NULL
I	NULL
Pio	NULL
B	NULL
&	NULL
HA-JNK1	NULL
IP	NULL
HA-Erk2	NULL
IP	NULL
8	NULL
5	NULL
Pb	NULL
OG	NULL
&	NULL
Â§Â§	NULL
&	NULL
&	NULL
5	NULL
&	NULL
z	NULL
=z	NULL
A|	NULL
|	NULL
Â«	NULL
@	NULL
-	NULL
Â»	NULL
Â«	NULL
-	NULL
Â»	NULL
&	NULL
g	NULL
&	NULL
Â§	NULL
&	NULL
5	NULL
g	NULL
0	NULL
o	NULL
o	NULL
g	NULL
(	NULL
immunoblot	NULL
)	NULL
-	NULL
#	NULL
(	NULL
immunoblot	NULL
)	NULL
Ã©	NULL
45	NULL
â	NULL
Ã©	NULL
)	NULL
Ag	NULL
,	NULL
g	NULL
$	NULL
a	NULL
a	NULL
o	NULL
$	NULL
a	NULL
a	NULL
a	NULL
Bg	NULL
o	NULL
c	NULL
a	NULL
3	NULL
9	NULL
2	NULL
a	NULL
2	NULL
Fel	NULL
E	NULL
â¬	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Induction	NULL
of	NULL
AP-1	NULL
,	NULL
JNK1	NULL
and	NULL
c-Jun	NULL
activity	NULL
by	NULL
LMP-1	NULL
in	NULL
transient	NULL
transfection	NULL
experiments	NULL
in	NULL
293	NULL
human	NULL
kidney	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
AP-1	NULL
induction	NULL
by	NULL
LMP-1	NULL
.	NULL

50	NULL
ng	NULL
of	NULL
the	NULL
AP-1	NULL
reporter	NULL
plasmid	NULL
pRTU14	NULL
was	NULL
transfected	NULL
together	NULL
with	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
the	NULL
LMP-1	NULL
expression	NULL
vector	NULL
pSV-LMP-1	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
the	NULL
JNK1	NULL
expression	NULL
vector	NULL
SR	NULL
@	NULL
-HA-JINK1	NULL
,	NULL
or	NULL
1	NULL
ug	NULL
pBXB-Raf	NULL
expressing	NULL
the	NULL
Raf	NULL
kinase	NULL
domain	NULL
BXB	NULL
.	NULL

Mock-transfected	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
carrier	NULL
DNA	NULL
and	NULL
pRTU14	NULL
only	NULL
.	NULL

24	NULL
h	NULL
post-transfection	NULL
luciferase	NULL
activities	NULL
were	NULL
measured	NULL
.	NULL

The	NULL
control	NULL
reporter	NULL
plasmid	NULL
pRTU1	NULL
lacking	NULL
the	NULL
four	NULL
TRE	NULL
sites	NULL
showed	NULL
minimal	NULL
basal	NULL
activity	NULL
only	NULL
,	NULL
and	NULL
was	NULL
not	NULL
inducible	NULL
by	NULL
any	NULL
of	NULL
the	NULL
applied	NULL
stimuli	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
JNK1	NULL
,	NULL
but	NULL
not	NULL
Erk2	NULL
,	NULL
is	NULL
induced	NULL
by	NULL
LMP-1	NULL
.	NULL

As	NULL
indicated	NULL
,	NULL
1	NULL
ug	NULL
pSV-LMP-1	NULL
,	NULL
pESBOS-CD40	NULL
,	NULL
or	NULL
carrier	NULL
DNA	NULL
were	NULL
transfected	NULL
together	NULL
with	NULL
1	NULL
ug	NULL
expressing	NULL
a	NULL
hemagglutinin	NULL
(	NULL
HA	NULL
)	NULL
-tagged	NULL
JNK1	NULL
(	NULL
HA-JNK1	NULL
)	NULL
or	NULL
SR	NULL
&	NULL
-HA-Erk2	NULL
expressing	NULL
a	NULL
HA-tagged	NULL
Erk2	NULL
(	NULL
HA-Erk2	NULL
)	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
CD40	NULL
were	NULL
stimulated	NULL
with	NULL
1	NULL
ug/ml	NULL
soluble	NULL
CD40	NULL
ligand	NULL
(	NULL
Immunex	NULL
)	NULL
for	NULL
24	NULL
h	NULL
to	NULL
trigger	NULL
CD40	NULL
activity	NULL
.	NULL

As	NULL
positive	NULL
controls	NULL
,	NULL
cells	NULL
were	NULL
UV-irradiated	NULL
with	NULL
50	NULL
mJ	NULL
in	NULL
a	NULL
Stratalinker	NULL
(	NULL
Stratagene	NULL
)	NULL
30	NULL
min	NULL
before	NULL
cell	NULL
harvest	NULL
or	NULL
stimulated	NULL
with	NULL
100	NULL
nM	NULL
TPA	NULL
for	NULL
30	NULL
min	NULL
.	NULL

24	NULL
h	NULL
post-transfection	NULL
kinase	NULL
activities	NULL
were	NULL
assayed	NULL
in	NULL
immunocomplex	NULL
kinase	NULL
assays	NULL
.	NULL

Results	NULL
of	NULL
HA-JNK1	NULL
assays	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
side	NULL
,	NULL
HA-Erk2	NULL
assays	NULL
on	NULL
the	NULL
right	NULL
side	NULL
.	NULL

Top	NULL
panels	NULL
,	NULL
autoradiographs	NULL
of	NULL
purified	NULL
glutathione-S-transferase	NULL
(	NULL
GST	NULL
)	NULL
-tagged	NULL
c-Jun	NULL
or	NULL
myelin	NULL
basic	NULL
protein	NULL
(	NULL
MBP	NULL
)	NULL
phosphorylated	NULL
by	NULL
immunoprecipitated	NULL
HA-JNK1	NULL
or	NULL
HA-Erk2	NULL
,	NULL
respectively	NULL
.	NULL

Middle	NULL
panels	NULL
,	NULL
-fold	NULL
induction	NULL
of	NULL
kinase	NULL
activities	NULL
as	NULL
quantitated	NULL
by	NULL
phosphoimager	NULL
analysis	NULL
.	NULL

Bottom	NULL
panels	NULL
,	NULL
immunoblots	NULL
of	NULL
the	NULL
immunoprecipitated	NULL
HA-JNK1	NULL
or	NULL
HA-Erk2	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Activation	NULL
of	NULL
the	NULL
c-Jun	NULL
N-terminal	NULL
transactivation	NULL
domain	NULL
by	NULL
LMP-1	NULL
.	NULL

50	NULL
ng	NULL
of	NULL
the	NULL
plasmid	NULL
pCMV-c-Jun	NULL
:	NULL
E2	NULL
expressing	NULL
a	NULL
fusion	NULL
protein	NULL
composed	NULL
of	NULL
the	NULL
c-Jun	NULL
N-terminal	NULL
transactivation	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
244	NULL
)	NULL
and	NULL
the	NULL
E2	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
250	NULL
to	NULL
410	NULL
)	NULL
,	NULL
and	NULL
100	NULL
ng	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
7xE2-oriLyt-Luc	NULL
(	NULL
L	NULL
)	NULL
containing	NULL
seven	NULL
E2-binding	NULL
sites	NULL
were	NULL
transfected	NULL
together	NULL
with	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
pSV-LMP-1	NULL
,	NULL
2	NULL
ug	NULL
SRu-HA-JNK1	NULL
,	NULL
or	NULL
2	NULL
ug	NULL
pBXB-Raf	NULL
.	NULL

Mock-transfected	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
c-Jun	NULL
:	NULL
EB2	NULL
transactivator	NULL
,	NULL
carrier	NULL
DNA	NULL
and	NULL
reporter	NULL
plasmids	NULL
only	NULL
.	NULL

24	NULL
h	NULL
post-transfection	NULL
luciferase	NULL
activities	NULL
were	NULL
measured	NULL
.	NULL

hypothesis	NULL
that	NULL
the	NULL
JNK	NULL
pathway	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
mediating	NULL
LMP-1	NULL
's	NULL
effects	NULL
on	NULL
c-Jun/AP-1	NULL
.	NULL

Dominant-negative	NULL
mutants	NULL
of	NULL
SEK1	NULL
block	NULL
LMP-1-induced	NULL
activities	NULL
of	NULL
JNK1	NULL
,	NULL
c-Jun	NULL
and	NULL
AP-1	NULL
SEK1	NULL
is	NULL
the	NULL
upstream	NULL
kinase	NULL
which	NULL
phosphorylates	NULL
and	NULL
thereby	NULL
activates	NULL
JNK1	NULL
(	NULL
Sanchez	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Dominant-negative	NULL
mutants	NULL
of	NULL
SEK1	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
block	NULL
JNK1	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
extracellular	NULL
and	NULL
intracellular	NULL
stimuli	NULL
(	NULL
Sanchez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Yan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
investigate	NULL
whether	NULL
LMP-1	NULL
triggers	NULL
AP-1-dependent	NULL
transcriptional	NULL
activation	NULL
via	NULL
the	NULL
JNK1	NULL
-	NULL
>	NULL
c-Jun	NULL
cascade	NULL
,	NULL
we	NULL
used	NULL
dominant-negative	NULL
mutants	NULL
of	NULL
SEK1	NULL
which	NULL
were	NULL
expected	NULL
to	NULL
interfere	NULL
with	NULL
-induced	NULL
JNK1	NULL
activity	NULL
as	NULL
well	NULL
as	NULL
c-Jun	NULL
and	NULL
AP-1-dependent	NULL
transcriptional	NULL
activation	NULL
.	NULL

Transient	NULL
coexpression	NULL
of	NULL
two	NULL
dominant-negative	NULL
SEK1	NULL
mutants	NULL
,	NULL
SEKI-KR	NULL
(	NULL
K129-R	NULL
)	NULL
(	NULL
Sanchez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
and	NULL
SEKI-AL	NULL
(	NULL
S220-A	NULL
,	NULL
T224-L	NULL
)	NULL
(	NULL
Yan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
severely	NULL
impaired	NULL
LMP-1-induced	NULL
JNK1	NULL
activity	NULL
in	NULL
293	NULL
cells	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

Coexpression	NULL
of	NULL
SEKI-KR	NULL
or	NULL
SEK1I-AL	NULL
led	NULL
to	NULL
a	NULL
70	NULL
%	NULL
and	NULL
77	NULL
%	NULL
decrease	NULL
in	NULL
LMP-1-induced	NULL
JNK1	NULL
activity	NULL
,	NULL
respectively	NULL
.	NULL

SEK1-KR	NULL
and	NULL
SEK	NULL
AL	NULL
also	NULL
blocked	NULL
LMP-1-triggered	NULL
activation	NULL
of	NULL
the	NULL
c-Jun	NULL
transactivation	NULL
domain	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
and	NULL
LMP-1-induced	NULL
AP-1-dependent	NULL
transcription	NULL
(	NULL
Figure	NULL
2C	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
clearly	NULL
demonstrate	NULL
that	NULL
LMP-1	NULL
can	NULL
induce	NULL
the	NULL
AP-1	NULL
transcription	NULL
factor	NULL
via	NULL
the	NULL
SEK1	NULL
-	NULL
>	NULL
JNK1I	NULL
-	NULL
>	NULL
c-Jun	NULL
cascade	NULL
.	NULL

6480	NULL
The	NULL
55	NULL
C-terminal	NULL
amino	NULL
acids	NULL
of	NULL
LMP-1	NULL
are	NULL
critically	NULL
involved	NULL
in	NULL
LMP-1	NULL
's	NULL
effects	NULL
on	NULL
AP-1	NULL
The	NULL
next	NULL
step	NULL
was	NULL
to	NULL
identify	NULL
the	NULL
domain	NULL
(	NULL
s	NULL
)	NULL
of	NULL
the	NULL
LMP-1	NULL
molecule	NULL
that	NULL
are	NULL
necessary	NULL
for	NULL
LMP-1	NULL
's	NULL
effects	NULL
on	NULL
AP-1	NULL
activity	NULL
.	NULL

Two	NULL
regions	NULL
in	NULL
the	NULL
cytoplasmic	NULL
C-terminus	NULL
of	NULL
LMP-1	NULL
have	NULL
been	NULL
identified	NULL
to	NULL
mediate	NULL
LMP-1	NULL
function	NULL
,	NULL
the	NULL
C-terminal	NULL
activation	NULL
regions	NULL
1	NULL
and	NULL
2	NULL
(	NULL
CTAR1	NULL
,	NULL
2	NULL
)	NULL
(	NULL
Huen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Kieff	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

Mutational	NULL
analysis	NULL
suggested	NULL
that	NULL
both	NULL
domains	NULL
are	NULL
involved	NULL
in	NULL
NF-KB	NULL
activation	NULL
by	NULL
LMP-1	NULL
(	NULL
Huen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Mitchell	NULL
and	NULL
Sugden	NULL
,	NULL
1995	NULL
;	NULL
Devergne	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Sandberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
CTAR1	NULL
(	NULL
amino	NULL
acids	NULL
194	NULL
to	NULL
231	NULL
)	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
TRAFs	NULL
1	NULL
,	NULL
2	NULL
and	NULL
3	NULL
(	NULL
Mosialos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Devergne	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Sandberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
whereas	NULL
TRAF	NULL
interaction	NULL
with	NULL
the	NULL
C-terminal	NULL
CTAR2	NULL
(	NULL
amino	NULL
acids	NULL
332	NULL
to	NULL
386	NULL
)	NULL
could	NULL
not	NULL
be	NULL
demonstrated	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
CTAR1	NULL
appears	NULL
to	NULL
be	NULL
dependent	NULL
on	NULL
TRAF-association	NULL
(	NULL
Devergne	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

To	NULL
learn	NULL
whether	NULL
CTAR1	NULL
or	NULL
CTAR2	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
AP-1	NULL
induction	NULL
by	NULL
LMP-1	NULL
,	NULL
we	NULL
transiently	NULL
transfected	NULL
LMP-1	NULL
mutants	NULL
harboring	NULL
deletions	NULL
in	NULL
both	NULL
regions	NULL
together	NULL
with	NULL
the	NULL
AP-1	NULL
reporter	NULL
contruct	NULL
pRTU14	NULL
in	NULL
293	NULL
cells	NULL
and	NULL
subsequently	NULL
assayed	NULL
for	NULL
AP-1-dependent	NULL
transcription	NULL
.	NULL

The	NULL
CTAR1	NULL
deletion	NULL
mutant	NULL
LMP-1A212-231	NULL
shows	NULL
strongly	NULL
reduced	NULL
TRAF1	NULL
and	NULL
barely	NULL
detectable	NULL
TRAF2	NULL
interaction	NULL
compared	NULL
with	NULL
wildtype	NULL
LMP-1	NULL
(	NULL
Sandberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
LMP-1	NULL
deletion	NULL
mutant	NULL
LMP-1A332-386	NULL
lacks	NULL
the	NULL
complete	NULL
CTAR2	NULL
region	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
3	NULL
,	NULL
deletion	NULL
of	NULL
CTAR2	NULL
completely	NULL
abolished	NULL
A	NULL
d	NULL
-	NULL
&	NULL
x	NULL
Â»	NULL
Fo	NULL
&	NULL
N	NULL
&	NULL
C	NULL
&	NULL
&	NULL
Â«	NULL
9Â°	NULL
5	NULL
l	NULL
$	NULL
53	NULL
}	NULL
Ao	NULL
â	NULL
11	NULL
â	NULL
ka	NULL
&	NULL
C	NULL
C	NULL
C	NULL
CF	NULL
JF	NULL
F	NULL
#	NULL
&	NULL
HA-JNK1	NULL
activity	NULL
ltt	NULL
1s	NULL
w	NULL
(	NULL
GST-c-Jun~P	NULL
)	NULL
x-fold	NULL
induction	NULL
-	NULL
Â»	NULL
|	NULL
1.0	NULL
8.8	NULL
2.7	NULL
2.0	NULL
0.6	NULL
0.6	NULL
HA-JINK1	NULL
IP	NULL
a	NULL
Â»	NULL
amp	NULL
ab	NULL
Â«	NULL
-o	NULL
-	NULL
Â»	NULL
am	NULL
(	NULL
immunoblot	NULL
)	NULL
LMP-1	NULL
induces	NULL
AP-1	NULL
via	NULL
JNK	NULL
u	NULL
O	NULL
[	NULL
relative	NULL
units	NULL
}	NULL
AP-1-dependent	NULL
luciferase	NULL
activity	NULL
[	NULL
relative	NULL
units	NULL
]	NULL
c-Jun	NULL
:	NULL
E2-dependent	NULL
luciferase	NULL
activity	NULL
LMP	NULL
LMP-1	NULL
+	NULL
SEKT-KR	NULL
'	NULL
z	NULL
F	NULL
l	NULL
$	NULL
%	NULL
&	NULL
S	NULL
&	NULL
$	NULL
8	NULL
E	NULL
mocketransfected	NULL
LMP-1	NULL
+	NULL
SEKT-AL	NULL
LMP-1	NULL
+	NULL
SEK1-KR	NULL
LMP-1	NULL
+	NULL
SEKT-AL	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Inhibition	NULL
of	NULL
LMP-1-induced	NULL
activity	NULL
of	NULL
the	NULL
JNK	NULL
cascade	NULL
after	NULL
coexpression	NULL
of	NULL
dominant-negative	NULL
mutants	NULL
of	NULL
SEK1	NULL
in	NULL
transiently	NULL
transfected	NULL
293	NULL
human	NULL
kidney	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Block	NULL
of	NULL
JNK1	NULL
induction	NULL
by	NULL
SEK1	NULL
mutants	NULL
.	NULL

1	NULL
ug	NULL
SRO-HA-JNK1	NULL
was	NULL
transfected	NULL
together	NULL
with	NULL
0.5	NULL
ug	NULL
pSV-LMP-1	NULL
,	NULL
1.5	NULL
ug	NULL
pEBG-SEK1-KR	NULL
expressing	NULL
SEK1-KR	NULL
or	NULL
pSEK1-AL/EE-CMV	NULL
expressing	NULL
SEK1-AL	NULL
.	NULL

Mock-transfected	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
carrier	NULL
DNA	NULL
and	NULL
SRQ-HA-JINK1	NULL
only	NULL
.	NULL

24	NULL
h	NULL
post-transfection	NULL
HA-INK1	NULL
kinase	NULL
activities	NULL
were	NULL
assayed	NULL
.	NULL

Top	NULL
panel	NULL
,	NULL
SDS-PAGE	NULL
and	NULL
autoradiography	NULL
of	NULL
GST-c-Jun	NULL
phosphorylated	NULL
by	NULL
immunoprecipitated	NULL
HA-JNK1	NULL
.	NULL

Middle	NULL
panel	NULL
,	NULL
-fold	NULL
induction	NULL
of	NULL
kinase	NULL
activities	NULL
as	NULL
quantitated	NULL
by	NULL
phosphoimager	NULL
analysis	NULL
.	NULL

Bottom	NULL
panel	NULL
,	NULL
immunoblots	NULL
of	NULL
the	NULL
immunoprecipitated	NULL
HA-JNK1	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Block	NULL
of	NULL
c-Jun	NULL
induction	NULL
by	NULL
SEK1	NULL
mutants	NULL
.	NULL

50	NULL
ng	NULL
pCMV-c-Jun	NULL
:	NULL
E2	NULL
and	NULL
100	NULL
ng	NULL
7xE2-oriLyt-Luc	NULL
(	NULL
L	NULL
)	NULL
were	NULL
transfected	NULL
together	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
pSV-LMP1	NULL
,	NULL
2	NULL
ug	NULL
pEBG-SEK1-KR	NULL
or	NULL
2	NULL
ug	NULL
pSEK1-AL/EE-CMV	NULL
as	NULL
indicated	NULL
.	NULL

Mock-transfected	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
carrier	NULL
DNA	NULL
,	NULL
transactivator	NULL
and	NULL
reporter	NULL
plasmids	NULL
only	NULL
.	NULL

24	NULL
h	NULL
post-transfection	NULL
luciferase	NULL
activities	NULL
were	NULL
measured	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Block	NULL
of	NULL
AP-1	NULL
induction	NULL
by	NULL
SEK1	NULL
mutants	NULL
.	NULL

As	NULL
in	NULL
(	NULL
B	NULL
)	NULL
,	NULL
cotransfection	NULL
of	NULL
50	NULL
ng	NULL
of	NULL
the	NULL
AP-1	NULL
reporter	NULL
plasmid	NULL
pRTU14	NULL
instead	NULL
of	NULL
pCMV-c-Jun	NULL
:	NULL
E2	NULL
and	NULL
7xE2-oriLyt-Luc	NULL
(	NULL
L	NULL
)	NULL
.	NULL

1	NULL
ug	NULL
of	NULL
the	NULL
LMP-1	NULL
and	NULL
SEK	NULL
mutant	NULL
expression	NULL
vectors	NULL
were	NULL
transfected	NULL
.	NULL

LMP-1	NULL
's	NULL
ability	NULL
to	NULL
induce	NULL
AP-1	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
functional	NULL
deletion	NULL
in	NULL
CTAR1	NULL
had	NULL
no	NULL
significant	NULL
consequences	NULL
on	NULL
LMP-1	NULL
's	NULL
effects	NULL
on	NULL
AP-1-dependent	NULL
transcription	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
demonstrate	NULL
that	NULL
CTAR2	NULL
,	NULL
but	NULL
not	NULL
CTAR1	NULL
,	NULL
is	NULL
required	NULL
for	NULL
AP-1	NULL
induction	NULL
by	NULL
LMP-1	NULL
.	NULL

Crosslinking	NULL
of	NULL
a	NULL
conditional	NULL
LMP-1	NULL
mutant	NULL
leads	NULL
to	NULL
the	NULL
immediate	NULL
induction	NULL
of	NULL
the	NULL
JNK1	NULL
pathway	NULL
It	NULL
was	NULL
important	NULL
to	NULL
show	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
LMP-1	NULL
on	NULL
the	NULL
JNK	NULL
cascade	NULL
and	NULL
AP-1	NULL
were	NULL
direct	NULL
and	NULL
did	NULL
not	NULL
involve	NULL
e.g	NULL
.	NULL

autocrine	NULL
loops	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
used	NULL
a	NULL
conditional	NULL
LMP-1	NULL
mutant	NULL
whose	NULL
activity	NULL
can	NULL
be	NULL
induced	NULL
at	NULL
will	NULL
.	NULL

The	NULL
mutant	NULL
LMP-1:3xFKBP12	NULL
lacks	NULL
the	NULL
transmembrane	NULL
segments	NULL
1	NULL
to	NULL
4	NULL
(	NULL
amino	NULL
acids	NULL
25	NULL
to	NULL
132	NULL
)	NULL
of	NULL
LMP-1	NULL
and	NULL
carries	NULL
a	NULL
FKBP12	NULL
trimer	NULL
at	NULL
its	NULL
C-terminus	NULL
(	NULL
Gires	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

This	NULL
LMP-1	NULL
mutant	NULL
localizes	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
but	NULL
fails	NULL
to	NULL
oligomerize	NULL
as	NULL
wildtype	NULL
LMP-1	NULL
.	NULL

Instead	NULL
,	NULL
LMP-1:3xFKBP12	NULL
can	NULL
be	NULL
oligomerized	NULL
by	NULL
the	NULL
use	NULL
of	NULL
a	NULL
drug	NULL
(	NULL
'AP1510	NULL
dimerizer	NULL
'	NULL
)	NULL
which	NULL
mediates	NULL
cross-linking	NULL
of	NULL
these	NULL
molecules	NULL
via	NULL
their	NULL
FKBP12	NULL
domains	NULL
.	NULL

Oligomerization	NULL
of	NULL
LMP-1:3xFKBP12	NULL
efficiently	NULL
induces	NULL
NF-KB	NULL
activation	NULL
(	NULL
Gires	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
demonstrating	NULL
that	NULL
crosslinking	NULL
of	NULL
this	NULL
LMP-1	NULL
mutant	NULL
can	NULL
trigger	NULL
signaling	NULL
activity	NULL
.	NULL

A	NULL
significant	NULL
increase	NULL
in	NULL
HA-JNKI1	NULL
activity	NULL
could	NULL
be	NULL
observed	NULL
with	NULL
LMP-1:3xFKBP12	NULL
as	NULL
shortly	NULL
as	NULL
5	NULL
min	NULL
after	NULL
adding	NULL
the	NULL
dimerizing	NULL
drug	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

The	NULL
maximum	NULL
HA-JNK1	NULL
induction	NULL
(	NULL
5.5-fold	NULL
)	NULL
was	NULL
reached	NULL
after	NULL
30	NULL
min	NULL
.	NULL

In	NULL
a	NULL
related	NULL
experiment	NULL
,	NULL
AP-1	NULL
activity	NULL
could	NULL
also	NULL
be	NULL
induced	NULL
by	NULL
LMP-1:3xFKBP12	NULL
within	NULL
30	NULL
to	NULL
60	NULL
min	NULL
after	NULL
administration	NULL
of	NULL
the	NULL
drug	NULL
as	NULL
demonstrated	NULL
in	NULL
transient	NULL
reporter	NULL
assays	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
induction	NULL
of	NULL
the	NULL
JNK	NULL
cascade	NULL
and	NULL
AP-1	NULL
is	NULL
an	NULL
immediate	NULL
and	NULL
therefore	NULL
most	NULL
likely	NULL
a	NULL
direct	NULL
response	NULL
to	NULL
LMP-1	NULL
signaling	NULL
events	NULL
.	NULL

Furthermore	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
JNK1	NULL
and	NULL
AP-1	NULL
induction	NULL
by	NULL
LMP-1	NULL
is	NULL
a	NULL
specific	NULL
16.0	NULL
14.0	NULL
12.0	NULL
10.0	NULL
8.0	NULL
[	NULL
relative	NULL
umits	NULL
)	NULL
6.0-	NULL
4.0~	NULL
AP-1-dependent	NULL
luciferase	NULL
activity	NULL
2.0	NULL
0.0-	NULL
mock-transfected	NULL
LMP-1	NULL
LMP-1A212-231	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

The	NULL
LMP-1	NULL
C-terminal	NULL
CTAR2	NULL
region	NULL
is	NULL
essential	NULL
for	NULL
LMP-1	NULL
's	NULL
effects	NULL
on	NULL
AP-1	NULL
.	NULL

Transient	NULL
transfections	NULL
in	NULL
293	NULL
human	NULL
kidney	NULL
cells	NULL
.	NULL

As	NULL
indicated	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
the	NULL
expression	NULL
vectors	NULL
pSV-LMP-1	NULL
expressing	NULL
wildtype	NULL
LMP-1	NULL
,	NULL
pSV-LMP-1A212-231	NULL
expressing	NULL
a	NULL
CTAR1	NULL
deletion	NULL
mutant	NULL
,	NULL
and	NULL
pSV-LMP-1A332-386	NULL
expressing	NULL
a	NULL
CTAR2	NULL
deletion	NULL
mutant	NULL
were	NULL
cotransfected	NULL
with	NULL
50	NULL
ng	NULL
of	NULL
the	NULL
AP-1	NULL
reporter	NULL
plasmid	NULL
pRTU14	NULL
.	NULL

24	NULL
h	NULL
post-transfection	NULL
luciferase	NULL
activities	NULL
were	NULL
assayed	NULL
.	NULL

and	NULL
regulated	NULL
signaling	NULL
event	NULL
and	NULL
not	NULL
just	NULL
an	NULL
unspecific	NULL
consequence	NULL
of	NULL
,	NULL
for	NULL
example	NULL
,	NULL
general	NULL
cell	NULL
stress	NULL
generated	NULL
by	NULL
LMP-1	NULL
expression	NULL
or	NULL
by	NULL
the	NULL
transfection	NULL
procedure	NULL
.	NULL

LMP-1	NULL
expression	NULL
parallels	NULL
JNK1	NULL
induction	NULL
in	NULL
B	NULL
cells	NULL
Since	NULL
LMP-1	NULL
is	NULL
genetically	NULL
involved	NULL
in	NULL
B-cell	NULL
immortalization	NULL
by	NULL
EBV	NULL
(	NULL
Kaye	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Kieff	NULL
,	NULL
1996	NULL
)	NULL
,	NULL
it	NULL
was	NULL
interesting	NULL
to	NULL
learn	NULL
whether	NULL
LMP-1	NULL
would	NULL
be	NULL
capable	NULL
to	NULL
induce	NULL
the	NULL
JNK	NULL
cascade	NULL
also	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Primary	NULL
human	NULL
B	NULL
cells	NULL
were	NULL
immortalized	NULL
with	NULL
a	NULL
recombinant	NULL
mini-EBV	NULL
(	NULL
Kempkes	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995a	NULL
)	NULL
carrying	NULL
a	NULL
tetracyline-regulated	NULL
LMP-1	NULL
allele	NULL
according	NULL
to	NULL
the	NULL
system	NULL
described	NULL
by	NULL
Gossen	NULL
,	NULL
Deuschle	NULL
and	NULL
collegues	NULL
(	NULL
Gossen	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Deuschle	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
(	NULL
E.Kilger	NULL
,	NULL
A.Kieser	NULL
and	NULL
W.Hammerschmidt	NULL
,	NULL
6481	NULL
A.Kieser	NULL
et	NULL
al	NULL
.	NULL

mock-transfected	NULL
LMP-1	NULL
:3xFKBP12	NULL
50	NULL
nM	NULL
dimerizer	NULL
0Â°	NULL
5Â°	NULL
15Â°	NULL
30Â°	NULL
60Â°	NULL
O	NULL
'	NULL
5Â°	NULL
15	NULL
``	NULL
30Â°	NULL
60Â°	NULL
HA-JNK1	NULL
activity	NULL
Â«	NULL
=o	NULL
aun	NULL
ath	NULL
(	NULL
GST-e-Jun~P	NULL
)	NULL
Â®	NULL
x-fold	NULL
induction	NULL
1.0	NULL
0.7	NULL
0.8	NULL
1.6	NULL
0.9	NULL
0.7	NULL
22	NULL
3.6	NULL
5.5	NULL
4.7	NULL
HA-JNK1	NULL
IP	NULL
movie	NULL
:	NULL
cap	NULL
a	NULL
(	NULL
immunoblot	NULL
)	NULL
Â»	NULL
a	NULL
Â»	NULL
oo	NULL
a	NULL
Â»	NULL
a	NULL
Â»	NULL
os	NULL
ca	NULL
Â»	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Immediate	NULL
induction	NULL
of	NULL
JNK1	NULL
activity	NULL
after	NULL
oligomerization	NULL
of	NULL
a	NULL
conditional	NULL
LMP-1	NULL
mutant	NULL
.	NULL

293	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
1	NULL
ug	NULL
SRu-HA-JINK1	NULL
together	NULL
with	NULL
50	NULL
ng	NULL
carrier	NULL
DNA	NULL
(	NULL
mock-transfected	NULL
)	NULL
or	NULL
50	NULL
ng	NULL
of	NULL
the	NULL
plasmid	NULL
pLMP-1:3xFKBP12	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
conditional	NULL
LMP-1	NULL
mutant	NULL
LMP-1:3xFKBP12	NULL
lacks	NULL
the	NULL
transmembrane	NULL
segments	NULL
1	NULL
to	NULL
4	NULL
(	NULL
amino	NULL
acids	NULL
25	NULL
to	NULL
132	NULL
)	NULL
but	NULL
carries	NULL
a	NULL
C-terminal	NULL
fusion	NULL
with	NULL
a	NULL
trimer	NULL
of	NULL
the	NULL
FKBP12	NULL
domain	NULL
.	NULL

Activity	NULL
of	NULL
LMP-1:3xFKBP12	NULL
can	NULL
be	NULL
triggered	NULL
by	NULL
administration	NULL
of	NULL
the	NULL
dimerizing	NULL
drug	NULL
AP1510	NULL
(	NULL
ARIAD	NULL
Pharmaceuticals	NULL
)	NULL
.	NULL

24	NULL
h	NULL
post-transfection	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
50	NULL
nM	NULL
of	NULL
AP1510	NULL
(	NULL
'dimerizer	NULL
'	NULL
)	NULL
for	NULL
different	NULL
periods	NULL
of	NULL
time	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
and	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
immunoprecipitated	NULL
HA-INK1	NULL
was	NULL
assayed	NULL
.	NULL

Top	NULL
panel	NULL
,	NULL
SDS-PAGE	NULL
and	NULL
autoradiography	NULL
of	NULL
GST-c-Jun	NULL
phosphorylated	NULL
by	NULL
the	NULL
immunoprecipitated	NULL
HA-JNK1	NULL
.	NULL

Middle	NULL
panel	NULL
,	NULL
-fold	NULL
induction	NULL
of	NULL
kinase	NULL
activities	NULL
as	NULL
quantitated	NULL
by	NULL
phosphoimager	NULL
analysis	NULL
.	NULL

Bottom	NULL
panel	NULL
,	NULL
immunoblots	NULL
of	NULL
the	NULL
immunoprecipitated	NULL
HA-JNK1	NULL
.	NULL

in	NULL
preparation	NULL
)	NULL
.	NULL

With	NULL
the	NULL
exception	NULL
of	NULL
LMP-1	NULL
,	NULL
all	NULL
other	NULL
EBV	NULL
genes	NULL
required	NULL
to	NULL
initiate	NULL
and	NULL
maintain	NULL
B-cell	NULL
immortalization	NULL
are	NULL
constitutively	NULL
expressed	NULL
from	NULL
this	NULL
mini-EBV	NULL
construct	NULL
(	NULL
Kempkes	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995a	NULL
)	NULL
(	NULL
E.Kilger	NULL
,	NULL
A.Kieser	NULL
and	NULL
W.Hammerschmidt	NULL
,	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

In	NULL
this	NULL
B-cell	NULL
system	NULL
,	NULL
removal	NULL
of	NULL
tetracycline	NULL
leads	NULL
to	NULL
a	NULL
drastic	NULL
downregulation	NULL
of	NULL
LMP-1	NULL
expression	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
and	NULL
the	NULL
cells	NULL
cease	NULL
to	NULL
proliferate	NULL
(	NULL
Kilger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

Endogenous	NULL
JNK	NULL
1	NULL
activity	NULL
could	NULL
barely	NULL
be	NULL
detected	NULL
in	NULL
this	NULL
state	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

Re-induction	NULL
of	NULL
LMP-1	NULL
expression	NULL
resulted	NULL
in	NULL
a	NULL
strong	NULL
induction	NULL
of	NULL
endogenous	NULL
JNK1	NULL
activity	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

After	NULL
4	NULL
days	NULL
of	NULL
restimulation	NULL
endogenous	NULL
JNKI1	NULL
activity	NULL
reached	NULL
its	NULL
maximum	NULL
level	NULL
of	NULL
a	NULL
12.6-fold	NULL
induction	NULL
.	NULL

Concomitantly	NULL
,	NULL
upon	NULL
re-induction	NULL
of	NULL
LMP-1	NULL
expression	NULL
the	NULL
cells	NULL
re-entered	NULL
the	NULL
cell	NULL
cycle	NULL
and	NULL
started	NULL
proliferating	NULL
again	NULL
(	NULL
E.Kilger	NULL
,	NULL
A.Kieser	NULL
and	NULL
W.Hammerschmidt	NULL
,	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
delivers	NULL
strong	NULL
evidence	NULL
that	NULL
induction	NULL
of	NULL
JNK	NULL
1	NULL
by	NULL
LMP-1	NULL
is	NULL
linked	NULL
to	NULL
proliferation	NULL
rather	NULL
than	NULL
cytotoxic	NULL
effects	NULL
.	NULL

Although	NULL
the	NULL
tetracycline-regulated	NULL
promoter	NULL
controling	NULL
LMP-1	NULL
expression	NULL
in	NULL
these	NULL
cells	NULL
appears	NULL
to	NULL
be	NULL
leaky	NULL
,	NULL
LMP-1	NULL
expression	NULL
levels	NULL
comparable	NULL
to	NULL
EBV-immortalized	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
(	NULL
LCLs	NULL
)	NULL
are	NULL
reached	NULL
at	NULL
day	NULL
3	NULL
after	NULL
tetracycline	NULL
restimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
;	NULL
Kilger	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

Most	NULL
likely	NULL
,	NULL
this	NULL
is	NULL
the	NULL
reason	NULL
for	NULL
the	NULL
boost	NULL
in	NULL
JNK1	NULL
activity	NULL
at	NULL
day	NULL
3	NULL
after	NULL
administration	NULL
of	NULL
tetracycline	NULL
.	NULL

At	NULL
that	NULL
point	NULL
,	NULL
LMP-1	NULL
expression	NULL
levels	NULL
might	NULL
exceed	NULL
a	NULL
certain	NULL
threshold	NULL
necessary	NULL
to	NULL
form	NULL
active	NULL
oligomeres	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
demonstrate	NULL
a	NULL
clear	NULL
link	NULL
between	NULL
LMP-1	NULL
expression	NULL
and	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
JNK	NULL
pathway	NULL
also	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

6482	NULL
0	NULL
&	NULL
s	NULL
tetracycline	NULL
g	NULL
restimulation	NULL
Â®	NULL
10	NULL
24	NULL
34	NULL
44d	NULL
JNK1	NULL
activity	NULL
waw	NULL
is	NULL
(	NULL
GST-c-Jun~P	NULL
)	NULL
x-fold	NULL
induction	NULL
-	NULL
#	NULL
Â»	NULL
|	NULL
1.0	NULL
1.7	NULL
2.2	NULL
7.3	NULL
126	NULL
IgG	NULL
heavy	NULL
chain	NULL
-	NULL
#	NULL
Â»	NULL
g	NULL
66	NULL
kD	NULL
JNK1	NULL
IP	NULL
-t	NULL
Â»	NULL
46	NULL
kD	NULL
(	NULL
immunoblot	NULL
)	NULL
f	NULL
o	NULL
igG	NULL
light	NULL
chain	NULL
-	NULL
Â»	NULL
08	NULL
&	NULL
&	NULL
8B	NULL
|	NULL
[	NULL
**	NULL
97.4	NULL
kD	NULL
LMP-1	NULL
cl	NULL
ees	NULL
66	NULL
kD	NULL
(	NULL
immunoblot	NULL
)	NULL
*	NULL
|	NULL
Â«	NULL
Â«	NULL
-	NULL
Â»	NULL
>	NULL
__	NULL
__	NULL
mme	NULL
amme||-	NULL
46	NULL
kD	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

LMP-1	NULL
induces	NULL
endogenous	NULL
JNK1	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
immortalized	NULL
with	NULL
a	NULL
mini-EBV	NULL
plasmid	NULL
carrying	NULL
a	NULL
tetracycline-conditional	NULL
LMP-1	NULL
allele	NULL
.	NULL

Primary	NULL
B	NULL
cells	NULL
immortalized	NULL
with	NULL
this	NULL
mini-EBV	NULL
were	NULL
kept	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
tetracycline	NULL
for	NULL
4	NULL
days	NULL
to	NULL
downregulate	NULL
LMP-1	NULL
expression	NULL
.	NULL

Subsequently	NULL
,	NULL
LMP-1	NULL
expression	NULL
was	NULL
re-induced	NULL
with	NULL
1	NULL
ug/ml	NULL
tetracycline	NULL
for	NULL
up	NULL
to	NULL
4	NULL
days	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

After	NULL
lysis	NULL
of	NULL
cells	NULL
,	NULL
endogenous	NULL
JNK1	NULL
was	NULL
immunoprecipitated	NULL
using	NULL
the	NULL
rabbit	NULL
anti-JNK1	NULL
antibody	NULL
C17	NULL
and	NULL
kinase	NULL
activities	NULL
were	NULL
determined	NULL
.	NULL

Top	NULL
panel	NULL
,	NULL
SDS-PAGE	NULL
and	NULL
autoradiography	NULL
of	NULL
GST-c-Jun	NULL
phosphorylated	NULL
by	NULL
the	NULL
immunoprecipitated	NULL
JNK1	NULL
.	NULL

Second	NULL
panel	NULL
from	NULL
top	NULL
,	NULL
-fold	NULL
induction	NULL
of	NULL
kinase	NULL
activities	NULL
as	NULL
quantitated	NULL
by	NULL
phosphoimager	NULL
analysis	NULL
.	NULL

Third	NULL
panel	NULL
from	NULL
top	NULL
,	NULL
immunoblots	NULL
of	NULL
the	NULL
immunoprecipitated	NULL
JNK1	NULL
using	NULL
the	NULL
rabbit	NULL
anti-JNK1	NULL
antibody	NULL
C-17	NULL
.	NULL

Bottom	NULL
,	NULL
immunoblot	NULL
analysis	NULL
of	NULL
LMP-1	NULL
expression	NULL
using	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
anti-LMP-1	NULL
antibody	NULL
.	NULL

Discussion	NULL
Here	NULL
we	NULL
show	NULL
that	NULL
Epstein-Barr	NULL
virus	NULL
LMP-1	NULL
induces	NULL
AP-1-dependent	NULL
transcription	NULL
via	NULL
the	NULL
SEK1	NULL
-	NULL
>	NULL
JNK1	NULL
-	NULL
>	NULL
c-Jun	NULL
N-terminus	NULL
cascade	NULL
.	NULL

This	NULL
is	NULL
the	NULL
first	NULL
report	NULL
demonstrating	NULL
that	NULL
LMP-1	NULL
can	NULL
trigger	NULL
the	NULL
activity	NULL
of	NULL
an	NULL
intracellular	NULL
signaling	NULL
kinase	NULL
.	NULL

This	NULL
finding	NULL
reveals	NULL
how	NULL
oncogenic	NULL
proteins	NULL
of	NULL
the	NULL
immortalizing	NULL
DNA	NULL
virus	NULL
EBV	NULL
could	NULL
interact	NULL
with	NULL
the	NULL
cellular	NULL
signaling	NULL
network	NULL
that	NULL
controls	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
.	NULL

JNK1	NULL
activation	NULL
via	NULL
an	NULL
inducible	NULL
LMP-1	NULL
mutant	NULL
allowed	NULL
us	NULL
to	NULL
demonstrate	NULL
that	NULL
cellular	NULL
effects	NULL
occur	NULL
within	NULL
minutes	NULL
after	NULL
induction	NULL
of	NULL
LMP-1	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
functionally	NULL
support	NULL
the	NULL
suggested	NULL
role	NULL
of	NULL
LMP-1	NULL
as	NULL
a	NULL
receptor-like	NULL
molecule	NULL
(	NULL
Devergne	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Kieff	NULL
,	NULL
1996	NULL
;	NULL
Gires	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Our	NULL
findings	NULL
are	NULL
even	NULL
more	NULL
surprising	NULL
taking	NULL
into	NULL
account	NULL
that	NULL
LMP-1	NULL
does	NULL
not	NULL
show	NULL
an	NULL
overall	NULL
homology	NULL
to	NULL
any	NULL
known	NULL
transmembrane	NULL
receptor	NULL
molecule	NULL
.	NULL

Although	NULL
LMP-1	NULL
binds	NULL
to	NULL
molecules	NULL
of	NULL
the	NULL
TRAF	NULL
family	NULL
via	NULL
its	NULL
CTAR1	NULL
domain	NULL
(	NULL
Mosialos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Devergne	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Sandberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
,	NULL
LMP-1	NULL
CTAR1	NULL
mutants	NULL
which	NULL
are	NULL
drastically	NULL
impaired	NULL
in	NULL
TRAF	NULL
binding	NULL
still	NULL
induce	NULL
NF-KB	NULL
almost	NULL
to	NULL
wildtype	NULL
levels	NULL
(	NULL
Huen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Mitchell	NULL
and	NULL
Sugden	NULL
,	NULL
1995	NULL
;	NULL
Sandberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
resembles	NULL
the	NULL
situation	NULL
observed	NULL
here	NULL
concerning	NULL
AP-1	NULL
induction	NULL
by	NULL
LMP-1	NULL
.	NULL

The	NULL
LMP-1	NULL
mutant	NULL
LMP-1A212-231	NULL
which	NULL
lacks	NULL
significant	NULL
TRAF	NULL
binding	NULL
activity	NULL
(	NULL
Sandberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
still	NULL
induces	NULL
AP-1-dependent	NULL
transcription	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
55	NULL
C-terminal	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
LMP-1	NULL
CTAR2	NULL
domain	NULL
appear	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
LMP-1-triggered	NULL
AP-1	NULL
activity	NULL
(	NULL
see	NULL
Figure	NULL
3	NULL
)	NULL
as	NULL
for	NULL
NF-KB	NULL
activity	NULL
(	NULL
Huen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Mitchell	NULL
and	NULL
Sugden	NULL
,	NULL
1995	NULL
;	NULL
Devergne	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
expression	NULL
of	NULL
LMP-1A332-386	NULL
appears	NULL
to	NULL
slightly	NULL
repress	NULL
the	NULL
level	NULL
of	NULL
cellular	NULL
AP-1	NULL
activity	NULL
(	NULL
see	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
this	NULL
effect	NULL
is	NULL
not	NULL
clear	NULL
,	NULL
yet	NULL
,	NULL
but	NULL
a	NULL
LMP-1	NULL
mutant	NULL
with	NULL
the	NULL
CTAR2	NULL
domain	NULL
directly	NULL
fused	NULL
to	NULL
LMP-1	NULL
's	NULL
transmembrane	NULL
domain	NULL
(	NULL
LMP-1A187-352	NULL
)	NULL
induces	NULL
JNKI	NULL
and	NULL
AP-1	NULL
activity	NULL
almost	NULL
to	NULL
levels	NULL
of	NULL
wildtype	NULL
LMP-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
supports	NULL
the	NULL
significance	NULL
of	NULL
the	NULL
results	NULL
observed	NULL
with	NULL
the	NULL
LMP-1	NULL
CTAR2	NULL
deletion	NULL
mutant	NULL
and	NULL
clearly	NULL
demonstrates	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
LMP-1	NULL
CTAR2	NULL
domain	NULL
for	NULL
LMP-1	NULL
's	NULL
effects	NULL
on	NULL
the	NULL
JNK1/c-Jun/	NULL
AP-1	NULL
pathway	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
C-terminal	NULL
CTAR2	NULL
domain	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
mediating	NULL
LMP-1	NULL
signaling	NULL
events	NULL
.	NULL

Albeit	NULL
we	NULL
show	NULL
that	NULL
the	NULL
SEK1/JNK1/c-Jun	NULL
N-terminus	NULL
cascade	NULL
can	NULL
mediate	NULL
AP-1	NULL
induction	NULL
by	NULL
LMP-1	NULL
,	NULL
this	NULL
finding	NULL
does	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
there	NULL
might	NULL
be	NULL
additional	NULL
LMP-1-triggered	NULL
pathways	NULL
leading	NULL
to	NULL
AP-1	NULL
induction	NULL
.	NULL

The	NULL
results	NULL
reported	NULL
here	NULL
bring	NULL
the	NULL
two	NULL
'loose	NULL
ends	NULL
'	NULL
,	NULL
LMP-1	NULL
on	NULL
one	NULL
side	NULL
and	NULL
the	NULL
nuclear	NULL
targets	NULL
of	NULL
LMP-1	NULL
on	NULL
the	NULL
other	NULL
,	NULL
closer	NULL
together	NULL
.	NULL

However	NULL
,	NULL
a	NULL
gap	NULL
remains	NULL
in	NULL
the	NULL
signaling	NULL
cascade	NULL
between	NULL
LMP-1	NULL
and	NULL
SEK	NULL
1	NULL
.	NULL

Currently	NULL
we	NULL
are	NULL
trying	NULL
to	NULL
identify	NULL
the	NULL
intermediates	NULL
to	NULL
make	NULL
the	NULL
ends	NULL
meet	NULL
.	NULL

In	NULL
spite	NULL
of	NULL
many	NULL
attempts	NULL
by	NULL
different	NULL
laboratories	NULL
,	NULL
no	NULL
molecule	NULL
(	NULL
s	NULL
)	NULL
could	NULL
be	NULL
identified	NULL
so	NULL
far	NULL
,	NULL
that	NULL
associate	NULL
(	NULL
s	NULL
)	NULL
with	NULL
the	NULL
CTAR2	NULL
domain	NULL
of	NULL
LMP-1	NULL
and	NULL
that	NULL
could	NULL
directly	NULL
link	NULL
the	NULL
LMP-1	NULL
very	NULL
C-terminus	NULL
to	NULL
downstream	NULL
signaling	NULL
events	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
preliminary	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
upstream	NULL
kinase	NULL
mediating	NULL
LMP-1	NULL
effects	NULL
on	NULL
JNKI1	NULL
is	NULL
not	NULL
MEKK	NULL
(	NULL
MEK	NULL
kinase	NULL
)	NULL
since	NULL
dominant-negative	NULL
mutants	NULL
of	NULL
MEKK	NULL
were	NULL
not	NULL
able	NULL
to	NULL
block	NULL
LMP-1-tiggered	NULL
JNK1	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
JNK	NULL
pathway	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
induction	NULL
of	NULL
cell	NULL
death	NULL
by	NULL
apoptosis	NULL
(	NULL
Xia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
reports	NULL
also	NULL
point	NULL
to	NULL
a	NULL
potential	NULL
role	NULL
of	NULL
the	NULL
JNK	NULL
cascade	NULL
in	NULL
non-cytotoxic	NULL
signaling	NULL
events	NULL
(	NULL
Shu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Natoli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

In	NULL
T	NULL
lymphocytes	NULL
,	NULL
integration	NULL
of	NULL
signals	NULL
that	NULL
lead	NULL
to	NULL
T-cell	NULL
activation	NULL
occurs	NULL
at	NULL
the	NULL
level	NULL
of	NULL
JNK	NULL
activation	NULL
(	NULL
Su	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Our	NULL
findings	NULL
suggest	NULL
a	NULL
role	NULL
of	NULL
JNK1	NULL
in	NULL
non-cytotoxic	NULL
LMP-1	NULL
signaling	NULL
since	NULL
induction	NULL
of	NULL
JNKI1	NULL
activity	NULL
by	NULL
LMP-1	NULL
in	NULL
B	NULL
cells	NULL
parallels	NULL
onset	NULL
of	NULL
proliferation	NULL
(	NULL
Figure	NULL
5	NULL
;	NULL
E.Kilger	NULL
,	NULL
A.Kieser	NULL
and	NULL
W.Hammerschmidt	NULL
,	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

Pos-sibly	NULL
,	NULL
concomitant	NULL
induction	NULL
of	NULL
anti-apoptotic	NULL
genes	NULL
by	NULL
LMP-1	NULL
(	NULL
Henderson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Laherty	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
allows	NULL
the	NULL
cells	NULL
to	NULL
escape	NULL
from	NULL
apoptosis	NULL
and	NULL
to	NULL
enter	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
triggered	NULL
by	NULL
AP-1	NULL
induction	NULL
via	NULL
JNKI1	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
the	NULL
proto-oncoprotein	NULL
AP-1	NULL
,	NULL
which	NULL
is	NULL
a	NULL
newly	NULL
identified	NULL
target	NULL
of	NULL
LMP-1	NULL
signaling	NULL
,	NULL
could	NULL
be	NULL
a	NULL
major	NULL
factor	NULL
in	NULL
cell	NULL
transformation	NULL
by	NULL
LMP-1	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
that	NULL
the	NULL
C-terminal	NULL
portion	NULL
of	NULL
the	NULL
LMP-1	NULL
molecule	NULL
(	NULL
amino	NULL
acids	NULL
232	NULL
to	NULL
386	NULL
)	NULL
is	NULL
essential	NULL
for	NULL
immortalization	NULL
of	NULL
B	NULL
lymphocytes	NULL
(	NULL
Moorthy	NULL
and	NULL
Thorley-Lawson	NULL
,	NULL
1993	NULL
;	NULL
Kaye	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
in	NULL
that	NULL
it	NULL
provides	NULL
a	NULL
growth	NULL
factor-like	NULL
signal	NULL
(	NULL
Kaye	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

We	NULL
demonstrate	NULL
here	NULL
that	NULL
the	NULL
C-terminal	NULL
CTAR2	NULL
domain	NULL
of	NULL
LMP-1	NULL
LMP-1	NULL
induces	NULL
AP-1	NULL
via	NULL
JNK	NULL
is	NULL
critically	NULL
involved	NULL
in	NULL
inducing	NULL
JNK1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
AP-1	NULL
activity	NULL
.	NULL

Activity	NULL
of	NULL
the	NULL
AP-1	NULL
transcription	NULL
factor	NULL
is	NULL
tightly	NULL
linked	NULL
to	NULL
the	NULL
control	NULL
of	NULL
cell	NULL
proliferation	NULL
(	NULL
Angel	NULL
and	NULL
Karin	NULL
,	NULL
1991	NULL
;	NULL
Karin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
AP-1	NULL
transcription	NULL
factor	NULL
is	NULL
induced	NULL
by	NULL
many	NULL
growth	NULL
factors	NULL
and	NULL
mitogens	NULL
(	NULL
Angel	NULL
and	NULL
Karin	NULL
,	NULL
1991	NULL
;	NULL
Karin	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
AP-1	NULL
is	NULL
a	NULL
good	NULL
candidate	NULL
for	NULL
mediating	NULL
the	NULL
growth	NULL
factor-like	NULL
effects	NULL
critical	NULL
for	NULL
LMP-1-mediated	NULL
immortalization	NULL
and	NULL
transformation	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
the	NULL
transcription	NULL
factor	NULL
AP-1	NULL
and	NULL
the	NULL
JNK	NULL
cascade	NULL
as	NULL
novel	NULL
targets	NULL
of	NULL
LMP-1	NULL
signaling	NULL
that	NULL
could	NULL
help	NULL
to	NULL
explain	NULL
the	NULL
immortalizing	NULL
,	NULL
transforming	NULL
,	NULL
and	NULL
growth	NULL
factor-like	NULL
effects	NULL
of	NULL
LMP-1	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
other	NULL
cells	NULL
which	NULL
EBV	NULL
infects	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Plasmids	NULL
and	NULL
expression	NULL
vectors	NULL
pSV-LMP-1	NULL
is	NULL
an	NULL
expression	NULL
vector	NULL
based	NULL
on	NULL
pHEBO	NULL
(	NULL
Sugden	NULL
et	NULL
aZ	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
in	NULL
which	NULL
LMP-1	NULL
is	NULL
expressed	NULL
from	NULL
a	NULL
subgenomic	NULL
EBV	NULL
fragment	NULL
under	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
SV40	NULL
promoter/enhancer	NULL
.	NULL

To	NULL
generate	NULL
pSV-LMP-1A212-231	NULL
and	NULL
pSV-LMP-1A332-386	NULL
,	NULL
the	NULL
LMP-1	NULL
deletion	NULL
mutants	NULL
LMP-1A212-231	NULL
(	NULL
kind	NULL
gift	NULL
from	NULL
M.Sandberg	NULL
)	NULL
and	NULL
LMP-1A332-386	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
same	NULL
vector	NULL
background	NULL
as	NULL
pSV-LMP-1	NULL
.	NULL

The	NULL
construction	NULL
of	NULL
the	NULL
LMP-1	NULL
mutant	NULL
LMP-1:3xFKBP12	NULL
has	NULL
been	NULL
described	NULL
recently	NULL
(	NULL
Gires	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

To	NULL
generate	NULL
pBXB-Raf	NULL
the	NULL
kinase	NULL
domain	NULL
of	NULL
human	NULL
Raf-l	NULL
(	NULL
human	NULL
Raf-1	NULL
with	NULL
a	NULL
deletion	NULL
from	NULL
amino	NULL
acids	NULL
26	NULL
to	NULL
303	NULL
)	NULL
was	NULL
cloned	NULL
into	NULL
pCMVS5	NULL
.	NULL

pESBOS-CD40	NULL
expresses	NULL
the	NULL
human	NULL
CD40	NULL
receptor	NULL
and	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
H.Engelmann	NULL
.	NULL

SR	NULL
&	NULL
-HA-JNK1	NULL
(	NULL
Minden	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
and	NULL
SR	NULL
&	NULL
-HA-Erk2	NULL
(	NULL
Minden	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
(	NULL
kind	NULL
gifts	NULL
from	NULL
M.Karin	NULL
)	NULL
,	NULL
pCMV-c-jun	NULL
:	NULL
E2	NULL
(	NULL
Baichwal	NULL
and	NULL
Tjian	NULL
,	NULL
1990	NULL
)	NULL
(	NULL
kind	NULL
gift	NULL
from	NULL
V.R.Baichwal	NULL
)	NULL
,	NULL
pEBG-SEK1-KR	NULL
(	NULL
Sanchez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
(	NULL
kind	NULL
gift	NULL
from	NULL
M.Baccarini	NULL
)	NULL
,	NULL
pSEK1-AL/	NULL
EE-CMV	NULL
(	NULL
Yan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
(	NULL
kind	NULL
gift	NULL
from	NULL
D.J.Templeton	NULL
)	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
.	NULL

The	NULL
reporter	NULL
plasmids	NULL
pRTU1	NULL
and	NULL
pRTU14	NULL
(	NULL
Kieser	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
(	NULL
kind	NULL
gifts	NULL
from	NULL
D.Bohmann	NULL
)	NULL
and	NULL
7xE2-oriLyt-Luc	NULL
(	NULL
L	NULL
)	NULL
(	NULL
Schepers	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
.	NULL

Cell	NULL
culture	NULL
methods	NULL
293	NULL
human	NULL
embryonic	NULL
kidney	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
full	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
GIBCO	NULL
)	NULL
.	NULL

For	NULL
transfections	NULL
,	NULL
cells	NULL
were	NULL
grown	NULL
to	NULL
subconfluence	NULL
in	NULL
6-well-plates	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
2	NULL
to	NULL
4	NULL
ug	NULL
DNA	NULL
using	NULL
the	NULL
Lipofectamine	NULL
reagent	NULL
(	NULL
GIBCO	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

Total	NULL
amounts	NULL
of	NULL
transfected	NULL
DNA	NULL
were	NULL
adjusted	NULL
using	NULL
salmon	NULL
testes	NULL
DNA	NULL
(	NULL
Sigma	NULL
)	NULL
as	NULL
a	NULL
carrier	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
medium	NULL
containing	NULL
1	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
for	NULL
24	NULL
h	NULL
and	NULL
treated	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

Subsequently	NULL
,	NULL
immunocomplex	NULL
kinase	NULL
assays	NULL
or	NULL
reporter	NULL
gene	NULL
assays	NULL
were	NULL
performed	NULL
.	NULL

Details	NULL
about	NULL
the	NULL
generation	NULL
of	NULL
B	NULL
cells	NULL
immortalized	NULL
with	NULL
a	NULL
mini-EBV	NULL
plasmid	NULL
carrying	NULL
a	NULL
conditional	NULL
LMP-1	NULL
allele	NULL
will	NULL
be	NULL
published	NULL
elsewhere	NULL
(	NULL
E.Kilger	NULL
,	NULL
A.Kieser	NULL
and	NULL
W.Hammerschmidt	NULL
,	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

Immortalized	NULL
B	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
full	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
with	NULL
1	NULL
pg/ml	NULL
tetracycline	NULL
to	NULL
ensure	NULL
LMP-1	NULL
expression	NULL
,	NULL
except	NULL
when	NULL
noted	NULL
otherwise	NULL
.	NULL

Immunocomplex	NULL
kinase	NULL
assays	NULL
,	NULL
immunoblotting	NULL
and	NULL
antibodies	NULL
Cells	NULL
were	NULL
treated	NULL
as	NULL
described	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
and	NULL
in	NULL
cell	NULL
culture	NULL
methods	NULL
.	NULL

Immunoprecipitations	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
Kieser	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
using	NULL
the	NULL
monoclonal	NULL
anti-hemagglutinin	NULL
antibody	NULL
12CA5	NULL
(	NULL
Boehringer	NULL
)	NULL
or	NULL
the	NULL
rabbit	NULL
anti-JNK1	NULL
antibody	NULL
C-17	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotech	NULL
.	NULL
)	NULL

,	NULL
immobilized	NULL
to	NULL
protein	NULL
G-Sepharose	NULL
beads	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
to	NULL
immunoprecipitate	NULL
HA-JNK1	NULL
or	NULL
HA-Erk2	NULL
,	NULL
or	NULL
endogenous	NULL
JNK1	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
vitro	NULL
immunocomplex	NULL
kinase	NULL
assays	NULL
with	NULL
the	NULL
immunoprecipitated	NULL
kinases	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
Kieser	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
using	NULL
glutathione-S-transferase	NULL
(	NULL
GST	NULL
)	NULL
-tagged	NULL
c-Jun	NULL
(	NULL
purified	NULL
from	NULL
E.coli	NULL
,	NULL
gift	NULL
from	NULL
M.Baccarini	NULL
)	NULL
or	NULL
myelin	NULL
basic	NULL
protein	NULL
(	NULL
MBP	NULL
,	NULL
Sigma	NULL
)	NULL
as	NULL
substrates	NULL
for	NULL
JNK1	NULL
or	NULL
Erk2	NULL
,	NULL
respectively	NULL
.	NULL

As	NULL
indicated	NULL
,	NULL
kinase	NULL
reactions	NULL
or	NULL
total	NULL
cell	NULL
lysates	NULL
were	NULL
seperated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
blotted	NULL
onto	NULL
Hybond-C	NULL
membranes	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Kinase	NULL
reactions	NULL
were	NULL
analysed	NULL
by	NULL
autoradiography	NULL
and	NULL
phosphoimager	NULL
scanning	NULL
.	NULL

The	NULL
following	NULL
antibodies	NULL
were	NULL
used	NULL
for	NULL
immunoblotting	NULL
:	NULL
the	NULL
rabbit	NULL
anti-JNK1	NULL
antibody	NULL
(	NULL
C-17	NULL
,	NULL
Santa	NULL
Cruz	NULL
Biotech	NULL
.	NULL
)	NULL

,	NULL
the	NULL
mouse	NULL
anti-Erk2	NULL
antibody	NULL
(	NULL
D-2	NULL
,	NULL
Santa	NULL
Cruz	NULL
Biotech	NULL
.	NULL
)	NULL

,	NULL
6483	NULL
A.Kieser	NULL
et	NULL
al	NULL
.	NULL

and	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
anti-LMP-1	NULL
antibody	NULL
(	NULL
Baichwal	NULL
and	NULL
Sugden	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

Luciferase	NULL
assays	NULL
Cells	NULL
were	NULL
treated	NULL
as	NULL
indicated	NULL
.	NULL

Subsequently	NULL
,	NULL
luciferase	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
total	NULL
cell	NULL
lysates	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Kieser	NULL
ef	NULL
aZ	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Acknowledgements	NULL
We	NULL
thank	NULL
M.Baccarini	NULL
,	NULL
V.R.Baichwal	NULL
,	NULL
D.Bohmann	NULL
,	NULL
H.Engelmann	NULL
,	NULL
M.Karin	NULL
,	NULL
M.Sandberg	NULL
and	NULL
D.J.Templeton	NULL
for	NULL
plasmids	NULL
;	NULL
H.Mischak	NULL
for	NULL
critically	NULL
reading	NULL
the	NULL
manuscript	NULL
;	NULL
Immunex	NULL
Corporation	NULL
,	NULL
Seattle	NULL
,	NULL
for	NULL
soluble	NULL
CD40	NULL
ligand	NULL
;	NULL
and	NULL
B.Sugden	NULL
for	NULL
antiserum	NULL
against	NULL
LMP-1	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
,	NULL
Dr	NULL
Mildred	NULL
Scheel	NULL
Stiftung	NULL
fir	NULL
Krebsforschung	NULL
and	NULL
institutional	NULL
grants	NULL
.	NULL

References	NULL
Angel	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
The	NULL
role	NULL
of	NULL
Jun	NULL
,	NULL
Fos	NULL
and	NULL
the	NULL
AP-1	NULL
complex	NULL
in	NULL
cell-proliferation	NULL
and	NULL
transformation	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1072	NULL
,	NULL
129-157	NULL
.	NULL

Baichwal	NULL
,	NULL
V.R	NULL
.	NULL

and	NULL
Sugden	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Transformation	NULL
of	NULL
Balb	NULL
3T3	NULL
cells	NULL
by	NULL
the	NULL
BNLF-1	NULL
gene	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

Oncogene	NULL
,	NULL
2	NULL
,	NULL
461-467	NULL
.	NULL

Baichwal	NULL
,	NULL
V.R	NULL
.	NULL

and	NULL
Tjian	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Control	NULL
of	NULL
c-Jun	NULL
activity	NULL
by	NULL
interaction	NULL
of	NULL
a	NULL
cell-specific	NULL
inhibitor	NULL
with	NULL
regulatory	NULL
domain	NULL
delta	NULL
:	NULL
differences	NULL
between	NULL
v-	NULL
and	NULL
c-Jun	NULL
.	NULL

Cell	NULL
,	NULL
63	NULL
,	NULL
815-825	NULL
.	NULL

Berberich	NULL
,	NULL
L.	NULL
,	NULL
Shu	NULL
,	NULL
G.	NULL
,	NULL
Siebelt	NULL
,	NULL
F.	NULL
,	NULL
Woodgett	NULL
,	NULL
.J.R	NULL
.	NULL

,	NULL
Kyriakis	NULL
,	NULL
J.M	NULL
.	NULL

and	NULL
Clark	NULL
,	NULL
E.A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Cross-linking	NULL
CD40	NULL
on	NULL
B	NULL
cells	NULL
preferentially	NULL
induces	NULL
stress-activated	NULL
protein	NULL
kinases	NULL
rather	NULL
than	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
15	NULL
,	NULL
92-101	NULL
.	NULL

Cohen	NULL
,	NULL
J.I	NULL
.	NULL

,	NULL
Wang	NULL
,	NULL
F.	NULL
,	NULL
Mannick	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
protein	NULL
2	NULL
is	NULL
a	NULL
key	NULL
determinant	NULL
of	NULL
lymphocyte	NULL
transformation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
9558-9562	NULL
.	NULL

Cordier	NULL
,	NULL
M.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Stable	NULL
transfection	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
nuclear	NULL
antigen	NULL
2	NULL
in	NULL
lymphoma	NULL
cells	NULL
containing	NULL
the	NULL
EBV	NULL
P3HR1	NULL
genome	NULL
induces	NULL
expression	NULL
of	NULL
B-cell	NULL
activation	NULL
molecules	NULL
CD21	NULL
and	NULL
CD23	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
64	NULL
,	NULL
1002-1013	NULL
.	NULL

Derijard	NULL
,	NULL
B.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Wu	NULL
,	NULL
LH	NULL
.	NULL

,	NULL
Barrett	NULL
,	NULL
T.	NULL
,	NULL
S	NULL
$	NULL
u	NULL
,	NULL
B.	NULL
,	NULL
Deng	NULL
,	NULL
T.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
and	NULL
Davis	NULL
,	NULL
R.J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
JNK1	NULL
:	NULL
a	NULL
protein	NULL
kinase	NULL
stimulated	NULL
by	NULL
UV	NULL
light	NULL
and	NULL
Ha-Ras	NULL
that	NULL
binds	NULL
and	NULL
phosphorylates	NULL
the	NULL
c-Jun	NULL
activation	NULL
domain	NULL
.	NULL

Cell	NULL
,	NULL
76	NULL
,	NULL
1025-1037	NULL
.	NULL

Deuschle	NULL
,	NULL
U.	NULL
,	NULL
Meyer	NULL
,	NULL
W.K	NULL
.	NULL

and	NULL
Thiesen	NULL
,	NULL
HJ	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Tetracycline-reversible	NULL
silencing	NULL
of	NULL
eukaryotic	NULL
promoters	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
1907-1914	NULL
.	NULL

Devergne,0	NULL
.	NULL

,	NULL
Hatzivassiliou	NULL
,	NULL
E.	NULL
,	NULL
Izumi	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Kaye	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Kleijnen	NULL
,	NULL
M.F	NULL
.	NULL

,	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Mosialos	NULL
,	NULL
G	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Association	NULL
of	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
with	NULL
an	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
domain	NULL
important	NULL
for	NULL
B-lymphocyte	NULL
transformation	NULL
:	NULL
role	NULL
in	NULL
NF-KB	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
7098-7108	NULL
.	NULL

Fahraeus	NULL
,	NULL
R.	NULL
,	NULL
Jansson	NULL
,	NULL
A.	NULL
,	NULL
Ricksten	NULL
,	NULL
A.	NULL
,	NULL
Sjoeblom	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Rymo	NULL
,	NULL
L	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Epstein-Barr	NULL
virus-encoded	NULL
nuclear	NULL
antigen	NULL
2	NULL
activates	NULL
the	NULL
viral	NULL
latent	NULL
membrane	NULL
protein	NULL
promoter	NULL
by	NULL
modulating	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
,	NULL
7390-7394	NULL
.	NULL

Farrell	NULL
,	NULL
PJ	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
immortalizing	NULL
genes	NULL
.	NULL

Trends	NULL
Microbiol	NULL
.	NULL

,	NULL
3	NULL
,	NULL
105-109	NULL
.	NULL

Gires,0	NULL
.	NULL

,	NULL
Zimber-Strobl	NULL
,	NULL
U.	NULL
,	NULL
Gonnella	NULL
,	NULL
R.	NULL
,	NULL
Ueffing	NULL
,	NULL
M.	NULL
,	NULL
Marschall	NULL
,	NULL
G.	NULL
,	NULL
Zeidler	NULL
,	NULL
R.	NULL
,	NULL
Pich	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Hammerschmidt	NULL
,	NULL
W.	NULL
(	NULL
1997	NULL
)	NULL
Latent	NULL
membrane	NULL
protein	NULL
1	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
mimics	NULL
a	NULL
constitutively	NULL
active	NULL
receptor	NULL
molecule	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
16	NULL
,	NULL
6131-6140	NULL
.	NULL

Gossen	NULL
,	NULL
M.	NULL
,	NULL
Bonin	NULL
,	NULL
A.L	NULL
.	NULL

and	NULL
Bujard	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Control	NULL
of	NULL
gene	NULL
activity	NULL
in	NULL
higher	NULL
eukaryotic	NULL
cells	NULL
by	NULL
prokaryotic	NULL
regulatory	NULL
elements	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

,	NULL
18	NULL
,	NULL
471-475	NULL
.	NULL

Grossman	NULL
,	NULL
S.R	NULL
.	NULL

,	NULL
Johannsen	NULL
,	NULL
E.	NULL
,	NULL
Tong	NULL
,	NULL
.X	NULL
.	NULL

,	NULL
Yalamanchili	NULL
,	NULL
R	NULL
.	NULL

and	NULL
KieffE	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
The	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
2	NULL
transactivator	NULL
is	NULL
directed	NULL
to	NULL
response	NULL
elements	NULL
by	NULL
the	NULL
J	NULL
kappa	NULL
recombination	NULL
signal	NULL
binding	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
,	NULL
7568-7572	NULL
.	NULL

Hammarskjold	NULL
,	NULL
M.L	NULL
.	NULL

and	NULL
Simurda	NULL
,	NULL
M.C	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
transactivates	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
through	NULL
induction	NULL
of	NULL
NF-KB	NULL
activity	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
66	NULL
,	NULL
6496-6501	NULL
.	NULL

Hammerschmidt	NULL
,	NULL
W.	NULL
and	NULL
Sugden	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Genetic	NULL
analysis	NULL
of	NULL
immortalizing	NULL
functions	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
,	NULL
340	NULL
,	NULL
393-397	NULL
.	NULL

6484	NULL
Henderson,8	NULL
.	NULL

,	NULL
Rowe	NULL
,	NULL
M.	NULL
,	NULL
Gregory	NULL
,	NULL
C.	NULL
,	NULL
Croom	NULL
,	NULL
C.D	NULL
.	NULL

,	NULL
Wang	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Longnecker	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Induction	NULL
of	NULL
bel-2	NULL
expression	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
protects	NULL
infected	NULL
B	NULL
cells	NULL
from	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
,	NULL
65	NULL
,	NULL
1107-1115	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
Ling	NULL
,	NULL
P.D	NULL
.	NULL

,	NULL
Hayward	NULL
,	NULL
S.D	NULL
.	NULL

and	NULL
Peterson	NULL
,	NULL
(	NULL
1994	NULL
)	NULL
Mediation	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
EBNAZ	NULL
transactivation	NULL
by	NULL
recombination	NULL
signal-binding	NULL
protein	NULL
J	NULL
kappa	NULL
.	NULL

Science	NULL
,	NULL
265	NULL
,	NULL
92-95	NULL
.	NULL

Hibi	NULL
,	NULL
M.	NULL
,	NULL
Lin	NULL
,	NULL
A.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
Minden	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Identification	NULL
of	NULL
an	NULL
oncoprotein-	NULL
and	NULL
UV-responsive	NULL
protein	NULL
kinase	NULL
that	NULL
binds	NULL
and	NULL
potentiates	NULL
the	NULL
c-Jun	NULL
activation	NULL
domain	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
,	NULL
2135-2148	NULL
.	NULL

Huen	NULL
,	NULL
D.S	NULL
.	NULL

,	NULL
Henderson	NULL
,	NULL
S.A.	NULL
,	NULL
Croom-Carter	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Rowe	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
The	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein-1	NULL
(	NULL
LMP1	NULL
)	NULL
mediates	NULL
activation	NULL
of	NULL
NF-KB	NULL
and	NULL
cell	NULL
surface	NULL
phenotype	NULL
via	NULL
two	NULL
effector	NULL
regions	NULL
in	NULL
its	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
.	NULL

Oncogene	NULL
,	NULL
10	NULL
,	NULL
549-560	NULL
.	NULL

Karin	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
The	NULL
regulation	NULL
of	NULL
AP-1	NULL
activity	NULL
by	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
,	NULL
16483-16486	NULL
.	NULL

Karin	NULL
,	NULL
M.	NULL
,	NULL
Liu	NULL
,	NULL
Z	NULL
.	NULL

and	NULL
Zandi	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
AP-1	NULL
function	NULL
and	NULL
regulation	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
9	NULL
,	NULL
240-246	NULL
.	NULL

Kaye	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Izumi	NULL
,	NULL
K.M	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
is	NULL
essential	NULL
for	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
9150-9154	NULL
.	NULL

Kaye	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Izumi	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Mosialos	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
The	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
cytoplasmic	NULL
carboxy	NULL
terminus	NULL
is	NULL
essential	NULL
for	NULL
B-lymphocyte	NULL
transformation	NULL
;	NULL
fibroblast	NULL
cocultivation	NULL
complements	NULL
a	NULL
critical	NULL
function	NULL
within	NULL
the	NULL
terminal	NULL
155	NULL
residues	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
69	NULL
,	NULL
675-683	NULL
.	NULL

Kempkes	NULL
,	NULL
B.	NULL
,	NULL
Pich	NULL
,	NULL
D.	NULL
,	NULL
Zeidler	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Hammerschmidt	NULL
W.	NULL
(	NULL
1995a	NULL
)	NULL
Immortalization	NULL
of	NULL
human	NULL
primary	NULL
B-lymphocytes	NULL
in	NULL
vifro	NULL
with	NULL
DNA	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
92	NULL
,	NULL
5875-5879	NULL
.	NULL

Kempkes	NULL
,	NULL
B.	NULL
,	NULL
Spitkovsky	NULL
,	NULL
D.	NULL
,	NULL
Jansen-Diirr	NULL
,	NULL
P.	NULL
,	NULL
Ellwart	NULL
,	NULL
J.W	NULL
.	NULL

,	NULL
Delecluse	NULL
,	NULL
H.-J	NULL
.	NULL

,	NULL
-	NULL
Rottenberger	NULL
,	NULL
C.	NULL
,	NULL
-	NULL
Kremmer	NULL
,	NULL
E.	NULL
,	NULL
-	NULL
Bornkamm	NULL
,	NULL
G.W	NULL
.	NULL

-	NULL
and	NULL
Hammerschmidt	NULL
,	NULL
W.	NULL
(	NULL
1995b	NULL
)	NULL
B-cell	NULL
proliferation	NULL
and	NULL
induction	NULL
of	NULL
early	NULL
G1-regulating	NULL
proteins	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
mutants	NULL
conditional	NULL
for	NULL
EBNAZ	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
14	NULL
,	NULL
88-96	NULL
.	NULL

Kieff,6	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
and	NULL
its	NULL
replication	NULL
.	NULL

In	NULL
Fields	NULL
,	NULL
B.N	NULL
.	NULL

,	NULL
Knipe	NULL
,	NULL
D.M	NULL
.	NULL

,	NULL
Howley	NULL
,	NULL
P.M.	NULL
,	NULL
Chanock	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Monath	NULL
,	NULL
T.P	NULL
.	NULL

,	NULL
Melnick	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
Roizman	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Straus	NULL
,	NULL
S.E	NULL
.	NULL

(	NULL
eds	NULL
)	NULL
,	NULL
Virology	NULL
.	NULL

Lippincott-Raven	NULL
Publishers	NULL
.	NULL

Philadelphia	NULL
,	NULL
PA	NULL
,	NULL
pp	NULL
.	NULL

2343-2396	NULL
.	NULL

Kicser	NULL
,	NULL
A.	NULL
,	NULL
Seitz	NULL
,	NULL
I.	NULL
,	NULL
AdlerH.S	NULL
.	NULL

,	NULL
CofferP	NULL
,	NULL
KremmerE	NULL
.	NULL

,	NULL
Crespo	NULL
,	NULL
P.	NULL
,	NULL
Gutkind	NULL
,	NULL
J.S	NULL
.	NULL

,	NULL
-	NULL
Henderson	NULL
,	NULL
D.W.	NULL
,	NULL
Mushinski	NULL
,	NULL
J.F	NULL
,	NULL
-	NULL
Kolch	NULL
,	NULL
W	NULL
.	NULL

-	NULL
and	NULL
Mischak	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Protein	NULL
kinase	NULL
C-zeta	NULL
reverts	NULL
v-raf	NULL
transformation	NULL
of	NULL
NIH-3T3	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
10	NULL
,	NULL
1455-1466	NULL
.	NULL

Klein	NULL
,	NULL
G	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
strategy	NULL
in	NULL
normal	NULL
and	NULL
neoplastic	NULL
B	NULL
cells	NULL
.	NULL

Cell	NULL
,	NULL
77	NULL
,	NULL
791-793	NULL
.	NULL

Knutson	NULL
,	NULL
J.C	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
The	NULL
level	NULL
of	NULL
c-fgr	NULL
RNA	NULL
is	NULL
increased	NULL
by	NULL
EBNA-2	NULL
,	NULL
an	NULL
Epstein-Barr	NULL
virus	NULL
gene	NULL
required	NULL
for	NULL
B-cell	NULL
immortalization	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
64	NULL
,	NULL
2530-2536	NULL
.	NULL

Laherty	NULL
,	NULL
C.D	NULL
.	NULL

,	NULL
Hu	NULL
,	NULL
H.M.	NULL
,	NULL
Opipari	NULL
,	NULL
A.W	NULL
.	NULL

,	NULL
Wang	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Dixit	NULL
,	NULL
V.M	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
The	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
gene	NULL
product	NULL
induces	NULL
A20	NULL
zinc	NULL
finger	NULL
protein	NULL
expression	NULL
by	NULL
activating	NULL
nuclear	NULL
factor	NULL
xB	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
267	NULL
,	NULL
24157-24160	NULL
.	NULL

Laux	NULL
,	NULL
G.	NULL
,	NULL
Adam	NULL
,	NULL
B.	NULL
,	NULL
Strobl	NULL
,	NULL
L.J	NULL
.	NULL

and	NULL
Moreau-Gachelin	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
The	NULL
Spi-1/PU.1	NULL
and	NULL
Spi-B	NULL
ets	NULL
family	NULL
transcription	NULL
factors	NULL
and	NULL
the	NULL
recombination	NULL
signal	NULL
binding	NULL
protein	NULL
RBP-J	NULL
kappa	NULL
interact	NULL
with	NULL
an	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
2	NULL
responsive	NULL
cis-element	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
13	NULL
,	NULL
5624-5632	NULL
.	NULL

Liecbowitz	NULL
,	NULL
D.	NULL
,	NULL
Wang	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Orientation	NULL
and	NULL
patching	NULL
of	NULL
the	NULL
latent	NULL
infection	NULL
membrane	NULL
protein	NULL
encoded	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
58	NULL
,	NULL
233-237	NULL
.	NULL

Martin	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Veis	NULL
,	NULL
D.	NULL
,	NULL
Korsmeyer	NULL
,	NULL
S.J	NULL
.	NULL

and	NULL
Sugden	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Latent	NULL
membrane	NULL
protein	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
induces	NULL
cellular	NULL
phenotypes	NULL
independently	NULL
of	NULL
expression	NULL
of	NULL
Bel-2	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
67	NULL
,	NULL
5269-5278	NULL
.	NULL

Minden	NULL
,	NULL
A.	NULL
,	NULL
-	NULL
Lin	NULL
,	NULL
A.	NULL
,	NULL
-	NULL
McMahon	NULL
,	NULL
M.	NULL
,	NULL
-	NULL
Lange-Carter	NULL
,	NULL
C.	NULL
,	NULL
Derijard	NULL
,	NULL
B.	NULL
,	NULL
Davis	NULL
,	NULL
R.J.	NULL
,	NULL
Johnson	NULL
,	NULL
G.L	NULL
.	NULL

and	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Differential	NULL
activation	NULL
of	NULL
ERK	NULL
and	NULL
JNK	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
by	NULL
Raf-1	NULL
and	NULL
MEKK	NULL
.	NULL

Science	NULL
,	NULL
266	NULL
,	NULL
1719-1723	NULL
.	NULL

Mitchell	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Sugden	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Stimulation	NULL
of	NULL
NF-KB-mediated	NULL
transcription	NULL
by	NULL
mutant	NULL
derivatives	NULL
of	NULL
the	NULL
latent	NULL
membrane	NULL
protein	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
69	NULL
,	NULL
2968-2976	NULL
.	NULL

Moorthy	NULL
,	NULL
R.K	NULL
.	NULL

and	NULL
Thorley-Lawson	NULL
,	NULL
D.A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
All	NULL
three	NULL
domains	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus-encoded	NULL
latent	NULL
membrane	NULL
protein	NULL
LMP-1	NULL
are	NULL
required	NULL
for	NULL
transformation	NULL
of	NULL
rat-l	NULL
fibroblasts	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
67	NULL
,	NULL
1638-1646	NULL
.	NULL

Mosialos	NULL
,	NULL
G.	NULL
,	NULL
Birkenbach	NULL
,	NULL
M.	NULL
,	NULL
Yalamanchili	NULL
,	NULL
R.	NULL
,	NULL
VanArsdale	NULL
,	NULL
T.	NULL
,	NULL
Ware	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
The	NULL
Epstein-Barr	NULL
virus	NULL
transforming	NULL
protein	NULL
LMP1	NULL
engages	NULL
signaling	NULL
proteins	NULL
for	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
family	NULL
.	NULL

Cell	NULL
,	NULL
80	NULL
,	NULL
389-399	NULL
.	NULL

Natoli	NULL
,	NULL
G.	NULL
,	NULL
-	NULL
Costanzo	NULL
,	NULL
A.	NULL
,	NULL
-	NULL
Ianni	NULL
,	NULL
A.	NULL
,	NULL
Templeton	NULL
,	NULL
D.J	NULL
.	NULL

,	NULL
Woodgett.J.R	NULL
.	NULL

,	NULL
Balsano	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Levrero	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Activation	NULL
of	NULL
SAPK/JNK	NULL
by	NULL
TNF	NULL
receptor	NULL
1	NULL
through	NULL
a	NULL
non-cytotoxic	NULL
TRAF2-dependent	NULL
pathway	NULL
.	NULL

Science	NULL
,	NULL
275	NULL
,	NULL
200-203	NULL
.	NULL

Sanchez	NULL
,	NULL
I.	NULL
,	NULL
Hughes	NULL
,	NULL
R.T.	NULL
,	NULL
Mayer	NULL
,	NULL
B.J	NULL
.	NULL

,	NULL
Yee	NULL
,	NULL
K.	NULL
,	NULL
Woodgett	NULL
,	NULL
J.R.	NULL
,	NULL
Avruch	NULL
,	NULL
J.	NULL
,	NULL
Kyriakis	NULL
,	NULL
J.M	NULL
.	NULL

and	NULL
Zon	NULL
,	NULL
L.I	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Role	NULL
of	NULL
SAPK/ERK	NULL
kinase-1	NULL
in	NULL
the	NULL
stress-activated	NULL
pathway	NULL
regulating	NULL
transcription	NULL
factor	NULL
c-Jun	NULL
.	NULL

Nature	NULL
,	NULL
372	NULL
,	NULL
794-198	NULL
.	NULL

Sandberg	NULL
,	NULL
M.	NULL
,	NULL
Hammerschmidt	NULL
,	NULL
W.	NULL
and	NULL
Sugden	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Characterization	NULL
of	NULL
LMP-1	NULL
's	NULL
association	NULL
with	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
,	NULL
and	NULL
TRAF3	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
71	NULL
,	NULL
4649-4656	NULL
.	NULL

Schepers	NULL
,	NULL
A.	NULL
,	NULL
Pich	NULL
,	NULL
D.	NULL
,	NULL
Mankertz	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Hammerschmidt	NULL
,	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Cis-acting	NULL
elements	NULL
in	NULL
the	NULL
lytic	NULL
origin	NULL
of	NULL
DNA	NULL
replication	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
67	NULL
,	NULL
4237-4245	NULL
.	NULL

Shu	NULL
,	NULL
J.	NULL
,	NULL
Hitomi	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Stacey	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Activation	NULL
of	NULL
JNK/SAPK	NULL
pathway	NULL
is	NULL
not	NULL
directly	NULL
inhibitory	NULL
for	NULL
cell	NULL
cycle	NULL
progression	NULL
in	NULL
NIH3T3	NULL
cells	NULL
.	NULL

Oncogene	NULL
,	NULL
13	NULL
,	NULL
2421-2430	NULL
.	NULL

S	NULL
$	NULL
u	NULL
,	NULL
B.	NULL
,	NULL
Jacinto	NULL
,	NULL
E.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Kallunki	NULL
,	NULL
T.	NULL
,	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Ben-Neriah	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
JNK	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
,	NULL
77	NULL
,	NULL
727-736	NULL
.	NULL

Sugden	NULL
,	NULL
B.	NULL
,	NULL
Marsh	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Yates	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
A	NULL
vector	NULL
that	NULL
replicates	NULL
as	NULL
a	NULL
plasmid	NULL
and	NULL
can	NULL
be	NULL
efficiently	NULL
selected	NULL
in	NULL
B-lymphoblasts	NULL
transformed	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
5	NULL
,	NULL
410-413	NULL
.	NULL

Tomkinson	NULL
,	NULL
B.	NULL
,	NULL
Robertson	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
proteins	NULL
EBNA-3A	NULL
and	NULL
EBNA-3C	NULL
are	NULL
essential	NULL
for	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
67	NULL
,	NULL
2014-2025	NULL
.	NULL

Wang	NULL
,	NULL
D.	NULL
,	NULL
Licbowitz	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
An	NULL
EBV	NULL
membrane	NULL
protein	NULL
expressed	NULL
in	NULL
immortalized	NULL
lymphocytes	NULL
transforms	NULL
established	NULL
rodent	NULL
cells	NULL
.	NULL

Cell	NULL
,	NULL
43	NULL
,	NULL
831-840	NULL
.	NULL

Wang	NULL
,	NULL
F.	NULL
,	NULL
Gregory	NULL
,	NULL
C.	NULL
,	NULL
Sample	NULL
,	NULL
C.	NULL
,	NULL
Rowe	NULL
,	NULL
M.	NULL
,	NULL
Liecbowitz	NULL
,	NULL
D.	NULL
,	NULL
Murray	NULL
,	NULL
R.	NULL
,	NULL
Rickinson	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
(	NULL
LMP1	NULL
)	NULL
and	NULL
nuclear	NULL
proteins	NULL
2	NULL
and	NULL
3C	NULL
are	NULL
effectors	NULL
of	NULL
phenotypic	NULL
changes	NULL
in	NULL
B	NULL
lymphocytes	NULL
:	NULL
EBNA-2	NULL
and	NULL
LMP1	NULL
cooperatively	NULL
induce	NULL
CD23	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
64	NULL
,	NULL
2309-2318	NULL
.	NULL

Westwick	NULL
,	NULL
J.K.	NULL
,	NULL
Cox	NULL
,	NULL
A.D.	NULL
,	NULL
Der	NULL
,	NULL
C.J	NULL
.	NULL

,	NULL
Cobb	NULL
,	NULL
M.H	NULL
.	NULL

,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Brenner	NULL
,	NULL
D.A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Oncogenic	NULL
Ras	NULL
activates	NULL
c-Jun	NULL
via	NULL
a	NULL
separate	NULL
pathway	NULL
from	NULL
the	NULL
activation	NULL
of	NULL
extracellular	NULL
signal-regulated	NULL
kinases	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
,	NULL
6030-6034	NULL
.	NULL

Xia	NULL
,	NULL
Z.	NULL
,	NULL
Dickens	NULL
,	NULL
M.	NULL
,	NULL
Raingeaud	NULL
,	NULL
J.	NULL
,	NULL
Davis	NULL
,	NULL
R.J	NULL
.	NULL

and	NULL
Greenberg	NULL
,	NULL
M.E	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Opposing	NULL
effects	NULL
of	NULL
ERK	NULL
and	NULL
JNK-p38	NULL
MAP	NULL
kinases	NULL
on	NULL
apoptosis	NULL
.	NULL

Science	NULL
,	NULL
270	NULL
,	NULL
1326-1331	NULL
.	NULL

Yan	NULL
,	NULL
M.	NULL
,	NULL
Dai	NULL
,	NULL
T.	NULL
,	NULL
Deak	NULL
,	NULL
J.C.	NULL
,	NULL
Kyriakis	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Zon	NULL
,	NULL
L.I	NULL
.	NULL

,	NULL
Woodgett	NULL
,	NULL
J.R	NULL
.	NULL

and	NULL
Templeton	NULL
,	NULL
D.J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Activation	NULL
of	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
by	NULL
MEKK1	NULL
phosphorylation	NULL
of	NULL
its	NULL
activator	NULL
SEK1	NULL
.	NULL

Nature	NULL
,	NULL
372	NULL
,	NULL
798-800	NULL
.	NULL

Zimber-Strobl	NULL
,	NULL
U.	NULL
,	NULL
Kempkes	NULL
,	NULL
B.	NULL
,	NULL
Marschall	NULL
,	NULL
G.	NULL
,	NULL
Zeidler	NULL
,	NULL
R.	NULL
,	NULL
Van	NULL
Kooten	NULL
,	NULL
C.	NULL
,	NULL
Banchereau	NULL
,	NULL
J.	NULL
,	NULL
Bormkamm	NULL
,	NULL
G.W	NULL
.	NULL

and	NULL
Hammerschmidt	NULL
,	NULL
W	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
(	NULL
LMP1	NULL
)	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
maintain	NULL
proliferation	NULL
of	NULL
B-cells	NULL
but	NULL
both	NULL
it	NULL
and	NULL
activated	NULL
CD40	NULL
can	NULL
prolong	NULL
their	NULL
survival	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
15	NULL
,	NULL
7070-7078	NULL
.	NULL

Zimber-Strobl	NULL
,	NULL
U.	NULL
,	NULL
-	NULL
Strobl	NULL
,	NULL
L.J	NULL
.	NULL

,	NULL
Meitinger	NULL
,	NULL
C.	NULL
,	NULL
Hinrichs	NULL
,	NULL
R.	NULL
,	NULL
-	NULL
Sakai	NULL
,	NULL
T.	NULL
,	NULL
Furukawa	NULL
,	NULL
T.	NULL
,	NULL
Honjo	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Bornkamm	NULL
,	NULL
G	NULL
.	NULL

W.	NULL
(	NULL
1994	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
2	NULL
exerts	NULL
its	NULL
transactivating	NULL
function	NULL
through	NULL
interaction	NULL
with	NULL
recombination	NULL
signal	NULL
binding	NULL
protein	NULL
RBP-J	NULL
kappa	NULL
,	NULL
the	NULL
homologue	NULL
of	NULL
Drosophila	NULL
Suppressor	NULL
of	NULL
Hairless	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
13	NULL
,	NULL
4973-4982	NULL
.	NULL

Received	NULL
on	NULL
July	NULL
16	NULL
,	NULL
1997	NULL
;	NULL
revised	NULL
on	NULL
August	NULL
13	NULL
,	NULL
1997	NULL
LMP-1	NULL
induces	NULL
AP-1	NULL
via	NULL
JNK	NULL
6485	NULL

